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CHAPTER 1. INTRODUCTION 
1.1 The importance of carbohydrates  
Carbohydrates are vital components of living creatures and are abundant in nature. 
Carbohydrates are also called saccharides or sugars, and function in our body as a source of 
energy for many important biological activities. Almost all types of cellular organisms contain 
different kinds of saccharides, which mediate many cellular interactions.1,2 Carbohydrates are 
frequently covalently bound to macromolecules and so form complicated structures of 
glycoproteins, glycolipids and glycoconjugates. The importance of carbohydrates makes them an 
area of study and interest in chemistry, biology and medicine.1 Glycobiology and glycochemistry 
are two significant fields that dominate research on carbohydrates. Sugars mainly consist of 
carbon, hydrogen and oxygen in their basic formula (CH2O)n,
3 and they can be classified based 
on the number of carbons they possess. They also can be joined into monosaccharides, 
disaccharides, or oligosaccharides. Monosaccharides, which are the basic form of carbohydrates, 
are divided into two classes: aldoses and ketoses. The former contains an aldehyde group at the 
chain terminus, while the ketoses have an internal ketone group along the chain.1 The simplest 
monosaccharide is glyceraldehyde (aldotriose) and has three carbons in its chain (Figure 1). 





Figure 1. Examples of Basic Structures of Carbohydrates.4 
Carbohydrates have in their structure, at least one chiral center. The number of isomers in 
carbohydrates increases with the increase in number of chiral centers present. Thus, the 
aldohexoses, with four stereogenic centers, have eight possible diastereomers, of which D-
glucose, D-galactose, and D-mannose are common.5 These common aldohexoses are 
supplemented by the common ketohexose D-fructose (Figure 2). 
 
Figure 2. Common Six Carbons Sugars. 
Oligosaccharides are constructed from two or more of monosaccharides connected by 
glycosidic linkages (Scheme 1). These linkages can be hydrolyzed and disconnected by suitable 
enzymes and reagents in important biochemical processes to form free monosaccharides.5 To 
build an oligosaccharide, the glycosidic bond is formed by a glycosylation reaction, which is a 
very important transformation in carbohydrate chemistry; glycosylations are achieved in nature 
by glycosyl transferases6 as well as in laboratory by using suitable promotors to connect between 
3 
 
glycosyl donor and accepter.7 Carbohydrates participate in various important biological 
processes in living cells, which are involved in curing various diseases such as cancer, influenza 
or bacterial infections.8,9 
 
Scheme 1. Hydrolysis and Formation of a Glycosidic Bond. 
1.2 Discovery of the sialic acids 
Sialic acid is a central molecule in the chemistry and glycobiology of carbohydrates. It is 
a polyhydroxy sugar acid and consists of a nine carbon backbone with an N-acetyl moiety 
attached to C5 (Figure 3).1,2  
 
Figure 3. The Open and Closed Structures of N-Acetylneuraminic Acid (Sialic Acid). 
 The isolation and discovery of sialic acid was a challenging task owing to the lack of 
sophisticated instruments at the time for the characterization of its structure.10 Its discovery 
opened a window to various applications in glycobiology and medicine. Blix in 1936 isolated a 
crystalline molecule from bovine submaxillary mucin that was later called sialic acid.11,12 In 
4 
 
1941, Klenk also isolated sialic acid from brain gangliosides.13 After this fascinating discovery, 
Blix, Klenk and Gottschalk published a formal nomenclature of the newly-isolated sialic acid 
and named it neuraminic acid.14 According to this nomenclature N-acetylneuraminic acid 
(Neu5Ac) is the parent of the sialic acid family, and is more formally called 2-keto-5-acetamido-
3,5-dideoxy-D-glycero-D-galactononulopyranos-1-onic acid.  In NMR studies of 13C-labeled 
Neu5Ac at pH~2, Neu5Ac was found to exist as an equilibrium mixture of two cyclic forms as 
well as other minor acyclic forms.15-17 The β-pyranose form of N-acetyl neuraminic acid is the 
major structure detected in solution in 91.2% at pH~2, whereas the α-pyranose is found as a 
minor component in 5.8%. The acyclic structures including the keto-hydrate, enol and keto 
forms, occur in lower concentrations of 1.9%, 0.5%, and 0.7%, respectively (Scheme 2).16 The 
detection of the correct forms of N-acetyl neuraminic acid is crucial for chemical and biological 
studies.  
 
Scheme 2. The Various Forms of Neu5Ac at Equilibrium.  
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1.3 The diversity of sialic acids in nature  
Sialic acids are present in the outmost end of most glycoproteins and glycolipids, and 
they are found in the wall cell membranes of vertebrate mammals and bacteria.1,2 The rich 
variety of sialic acids that are found in animals, are distributed in deuterostomes specifically in 
vertebrates.2 Some types of sialic acids in bacterial glycoproteins, exist as polysaccharides and 
lipopolysaccharides such as the conjugates of pseudaminic acid and legionaminic acid.2 The 
numbers of naturally occurring sialic acids are increasing in the literature due to the fascinating 
role that they play nowadays in glycobiology research. The most common sialic acid found in 
nature is N-acetylneuraminic acid (Neu5Ac), which is found in the outmost terminal position of 
glycoproteins in vertebrates and invertebrates. Neu5Ac is abundant in humans and animals, and 
is considered the parent of most sialic acid derivatives.2,3,18,19 N-Acetylneuraminic acid mediates 
many biological processes and it is frequently connected to the terminus of glycoproteins and 
glycolipids through α(2-3) or α(2-6) linkages.2 The successful isolation of neuraminic acid led 
the scientific community become interested in its biosynthesis. NeuAc5 is synthesized from 
pyruvate and a naturally occurring N-acetylhexosamine. Rosemane and Comb successfully 
synthesized N-acetylneuraminic acid from pyruvic acid and N-acetyl-D-mannosamine using an 
aldolase type enzyme called N-acyl neuraminic acid-aldolase (NANA-aldolase).12,20 N-
Acetylglucosamine is believed to be an important component of NeuAc biosynthesis in that N-
acetylglucosamine epimerizes to N-acetyl-D-mannosamine, which reacts with pyruvate in the 




Scheme 3. Biosynthesis of N-Acetylneuraminic Acid. 
N-Glycolylneuraminic acid (Neu5Gc) 2 is less abundant in nature compared to NeuAc5, 
but it is the second most abundant sialic acid in nature (Figure 4). Neu5Gc is mostly found in 
animals but is rare in humans, where it was found to be expressed at abnormal levels in human 
cancers.3 The third most abundantly naturally occurring sialic acid is  the deaminated neuraminic 
acid 2-keto-3-deoxy-D-glycero-D-galactononulosonic acid (KDN) 3,21,22 which occurs in many 
bacteria and lower vertebrates and is found in many of the glycoproteins and glycolipids.23 KDN 
differs from the Neu5Ac structure at the 5-postion where the amide is replaced by a hydroxy 
group (Figure 4). 
 
Figure 4. The Most Abundant Naturally Occurring Sialic Acids. 
The sialic linkages that are abundant in nature, are α(2→3), α(2→4), α(2→6), and 
α(2→8). These types of linkages are found in NeuAc as well as KDN.21 In animal cells, NeuAc 
exists mostly as a conjugate that is connected with other glycoproteins, whereas KDN is 
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abundant as a free monosaccharide form.22 A large quantity of KDN as a free sugar is found in 
red blood cells as well as cancer cells.22 KDN is formed by a biosynthesis pathway from 
mannose (Man), which is transformed to its 6-phosphate (Man-6-P). The condensation of (Man-
6-P) with phosphoenolpyruvate (PEP) by the enzyme called KDN-9-P synthase (KPS), forms 
KDN-9-P that is a precursor of KDN (Scheme 5).22,24  
 
Figure 5. The Biosynthesis of KDN. 
Much attention is focused on the synthesis of KDN and its derivatives because of their 
elevated observation level in some human cancer cells and tissues.22  
1.4 Biological significance of sialic acid.  
The presence or the absence of N-acetylneuraminic acid in glycoproteins was found to 
affect the inflammatory actions of human immunoglobulin G (IgG).25 In vivo, sialic acids in 
general have an important role as glycoconjugates, for supplying of the negative charge on 
cellular membranes. Moreover, sialic acids play a vital role in the transfer of information 
between the cells as well as recognition and determination of the glycoprotein structures and 
bioactivities.26 Sialic acid acids have important activities in masking cellular antigens and 
reducing the immunochemical reaction of degenerated cells.27,28 Sialylatd glycoproteins  play a 
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role in strengthening the cornea in the human eyeballs.29 Recent studies suggested that metastatic 
breast cancer increases after targeting a sialic acid glycosides in tumor cells.30 These many and 
varied biological activities make sialic acid research a central area of interest in medicine and the 
pharmaceutical sciences. 
1.5 Sialic acid-based inhibitors of neuraminidase  
Flu (cold) is a well-known epidemic infectious disease that both humans and animals 
have struggled to cope for millennia; it is caused by influenza viruses. Infection by the influenza 
viruses is harmful and can lead to death, especially among elders and children.31,32 Influenza 
viruses are found to bind sialic acids in cell membranes.33 Each type of influenza virus can 
recognize different types of sialic acid and the linkages that connect them.3 There are three types 
of influenza virus: A, B, and C. Influenza A is the most common form that causes the flu, it 
contains the haemagglutinin (H) and neuraminidase (N) glycoproteins, which significantly 
impact the levels and so the activity of sialic acids in the living cells.34,35  This leads to the 
classification of influenza A to several subtypes; Spanish influenza (H1N1), Asian influenza 
(H2N2), Hong Kong influenza (H3N2), and avian influenza (H5N1).36,37 The treatment of 
influenza depends mostly on the regulation and manipulation of the enzymes that are responsible 
for the sialic acid behavior by means of their inhibition. Developing an inhibitor that would 
prevent the action of neuraminidase, is an important subject of interest in the drug discovery, and 
neuraminidase inhibitors are most effective drugs for treating influenzas, such that chemists 




1.5.1 The action of neuraminidase enzymes 
Sialidases (neuraminidases) are a broad class of enzymes that have been isolated from 
animal tissue and bacteria. Neuraminidases (acetylneuraminyl hydrolases) have been isolated 
and crystallized to gain more insight to their biological and chemical actions. They occur in 
vertebrates and bacteria in animal cells as well as in influenza viruses.28,40 Acetylneuraminyl 
hydrolase also called α-neuraminidase (EC 3.2.1.18) hydrolyzes the α-ketosidic linkages: 
α(2→3), α(2→6), and α(2→8) of the outmost sialoside residues in glycoproteins, gangliosides or 
colominic acids leading to release of  free Neu5Ac, hence destroying the receptors for the virus 
(Scheme 4).35,40-42  
 
Scheme 4. Neuraminidase (EC 3.2.1.18) Cleaves the Glycosidic Bond and Releases 
Sialic Acid. 
1.5.2 The discovery of neuraminidase inhibitors  
The first neuraminidase inhibitor reported was 2,3-didehydro-2-deoxy-N-
acetylneuraminic acid (DANA) 6 (Figure 6), which is an unsaturated derivative of NeuAc5. Its 
structure is derived from neuraminic acid and its conformation resembles the intermediate that is 
formed as NeuAc5 is liberated from the terminal glycoprotein (Scheme 4).43 DANA was not 
commercialized but its structure was used as a template for the synthesis of analogues to 
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discover new inhibitors of neuraminidase that could be more potent and effective as drugs. For 
instance, 2-deoxy-2,3-didehydro-N-trifluoracetylneuraminic acid 7 (Figure 6) was derived from 
DANA and displayed enhanced potent activity.31, 32 
 
Figure 6. DANA and 5-N-Trifluroacetyl Inhibitors. 
Zanamivir is another analogue of DANA and is considered to be the most effective 
neuraminidase inhibitor so far.37 Zanamivir is commercialized as Relenza, and its structure is 
based on 2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid. Its synthesis has 
been described multiple times,39 but the first synthesis was reported by a group at Monash 
University in Australia who synthesized it from NANA (Scheme 5).36,43 Zanamivir has been 
subjected to several rounds of structural modifications and many analogues were prepared to 
develop more potent inhibitors of neuraminidase.43 The 4-guanidinyl moiety in Zanamivir is 
found to play an important role in binding the target protein.36 
 
Scheme 5. The First Synthesis of Zanamivir. 
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Several further neuraminidase inhibitors have been discovered for influenza treatment, 
such as oseltamivir (Tamiflu), laninamivir and peramivir (Figure 7),35 of which one, Tamiflu, 
has reached the market. It is derived from a cyclohexene ring and also mimics the intermediate 
structure 5 in the hydrolysis of  the terminal sialic acid of glycoproteins.44 
 
Figure 7. Further Inhibitors of Neuraminidase. 
1.6 Oxidative deamination in organic synthesis  
A deamination reaction is the transformation of an amino group to another non-nitrogen 
based functional group; they are widely used in organic syntheses. Synthetic chemists use 
deamination to convert anilines to phenols, aryl halides, and aryl esters. These conversions 
proceed via the formation of diazonium salt intermediates, which are susceptible to nucleophilic 
attack by various nucleophiles (Scheme 6).45-47 
 
Scheme 6. Deamination in Aromatic Systems.  
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Aliphatic amines are also converted to the corresponding alcohols, alkyl halides and 
esters via the formation of alkane diazonium salts in a nitrosation reaction of amines (Scheme 
7).33 A general rule in oxidative deamination is that the acidity of the reaction media is crucial for 
a successful conversion.  
 
Scheme 7. Deamination in Aliphatic Systems. 
1.7 Modification of sialic acids 
Many important modifications of sialic acid have been reported in the literature, giving 
rise to more diverse structures of sialic acids.2,48 Even minor modifications in sialic acids can 
affect their biological role significantly.2,4 Various chemical modifications of N-acetylneuraminic 
acid were achieved either to improve the chemical stereoselectivity of sialylation reactions or to 
develop the biology for medicinal and drug discovery purposes, such as the develop of 
carbohydrate-based drugs as antiviral or antibacterial agents. In particular, the chemical 
modification of the Neu5Ac at the 5-postion showed improved reactivity and selectivity in 
glycosylation reactions by influencing both sialic acid donors and acceptors.48,49  
1.7.1 Modification at the 5-postion of sialic acid. 
The effect of modification at the 5-postion in sialic acid donors or acceptors was 
demonstrated by several labs. Boons and co-workers introduced the N-acetylacetamido (NAc2) 
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group in sialic acids in place of the original acetamido group (NHAc). This modification showed 
shorter time of the glycosylation reaction as well as increased yields. Thus, with the (NAc2) 
group, the sialylation reaction was completed in 5 min. On the hand, with the native NHAc 
group in the sialic acid donor, sialylation reactions required 2-6 hours under comparable 
conditions (Scheme 8).50 
 
Scheme 8. Comparison Between NAc2 and NHAc Bearing Sialyl Donors. 
1.7.2 Modification as an azide group   
The Crich lab achieved α-selective glycosylations in the synthesis of equatorial 
glycosides through modification at the 5-postion by the installation of an axial azide in the D-
glycero-D-gulo sialic acid adamantanyl thioglycoside donor 24. The high stereoselectivity of this 
reaction was accomplished due to the use of lower temperature – 78 C, the installation of an 
azido moiety at the 5-postion of the donor, and the trans–gauche (tg) conformation of the side 
chain.51,52 This modification enabled a coupling to even the least reactive acceptors, including 
hindered secondary alcohols such as 25. In addition, the employment of an equatorial azide at the 





Scheme 9. α-Selective Glycosylation Using a 5-Azido-Protected Donor. 
Schmidt53 was able to introduce the azido group on C5 in the sialic acid by a Zbiral 
deamination reaction, and Wong54 demonstrated improved α-selectivity with the azido protected 
sialic acid donors and acceptors. Introduction of a 5-N-trifluoracetyl group in place of the NHAc 
at the 5-postion in the glycosyl acceptor also revealed improved stereoselectivity, as well as 
enhanced yields in the glycosylation reaction compared to the original NHAc group (Scheme 
10).55 
 
Scheme 10. N-TFA and NHAc Groups in Acceptors 
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1.7.3 The O-4, N-5-oxazolidinone moiety  
Modification of sialic acid can also be accomplished by the employment of an 
oxazolidinone moiety spanning the 4- and 5-postions of a sialyl donor 34. The Crich lab has 
provided numerous examples of the advantageous use of the O-4, N-5-oxazolidinone-protected 
donor in α-selective sialylation at – 78 C in a binary solvent of acetonitrile and dichloromethane 
(Scheme 11). This protecting group provides higher yields and high α-selective 
glycosylations.56,57 The sialic acid oxazolidinone derivatives have been utilized widely in the 
synthesis of α-selective sialosides by many other labs.56-61 
 
Scheme 11. The Use of Oxazolidinone-Protected Donors for α-Selective Glycosylation. 
1.7.4 Modification of C5 by the isothiocyanato moiety 
It was also found that modification of sialyl donors by installation of an isothiocyanato 
group at the 5-postion provides a practical access to the stereoselective α-sialosides as well as 
enabling the diversification of sialic acids. Thus, the Crich lab obtained high α-selectivity and 
high yields in coupling reactions conducted at − 78 C, between a thiosialoside donor protected 




Scheme 12. Glycosylation Reactions Using an Isothiocyanato Derivative. 
1.8 White’s oxidative deamination  
White used the deamination reaction oxidatively for the degradation of aliphatic amides 
through the decomposition of N-nitroso derivates 43, followed by the extrusion of molecular 
nitrogen to provide the corresponding esters 44. In the thermal conditions of the White method, 
the N-nitrosoamides of secondary and tertiary amides decompose to form the corresponding 
products 47 frequently with retention of configuration. The White reaction was suggested to 
proceed through the formation and degradation of two ion pairs 45 and 46 after acyl migration 
from nitrogen to oxygen (Scheme 13).63-66   
 
Scheme 13. White’s Degradation of Aliphatic Amides. 
1.9 Ogura and Zbiral’s oxidative deamination  
The primary application of the oxidative deamination reaction in carbohydrate chemistry 
is to convert N-acetylneuraminic acid to the biologically important molecule KDN. The 
oxidative deamination has also proven to be a pivotal transformation in the synthesis of 
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pseudaminic acid glycosides, which are found in the lipopolysaccharides from Pseudomonas 
aeruginosa and other pathogens.51,67,68 Ogura was the first to apply the oxidative deamination in 
the transformation of an acetyl glycoside of Neu5Ac to obtain a KDN derivative; this 
transformation was accompanied by a ring contracted furan product, although no spectral data 
for the furanose ring were presented (Scheme 14).69 Zbiral and Schreiner contributed a 
significant advance in the oxidative deamination by developing practical conditions. The 
formation of KDN resulted from the treatment of the N-nitrosoamide with sodium isopropoxide 
and trifluoroethanol followed by the addition of acetic acid. The Zbiral laboratory also observed 
the formation of and characterized the ring contracted product (Scheme 14), although they did 
not determine the configuration at both C5 and C6.70 
 
Scheme 14. Ogura’s and Zbiral’s Deamination. 
1.10.1 Application of the Zbiral oxidative deamination in the Crich lab  
The Crich lab have been studying intensively the oxidative deamination for modification 
and diversification of N-acetylneuraminic acid, with a view to achieving chemoselective and 
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stereoretentive glycosyl donors. Prior to their work, acetic acid was the main nucleophile used in 
oxidative deamination to make KDN and its derivatives.69,70 However, the Crich group 
demonstrated that thioacetic acid, (HF·pyridine), and propargyl alcohol can be used as 
nucleophiles in the presence of external acid (HBF4.Et2O) to functionalize Neu5Ac derivatives. 
The conditions used in these examples are the treatment of N-nitroso derivatives with 
trifluoroethanol, sodium isopropoxide and isopropanol at – 10 C for 10 min, followed by the 
addition of a nucleophile and then, followed immediately by that of HBF4.Et2O. The deaminated 
products were reported as being isolated in reasonable yields accompanied by other byproducts. 
Retention of stereochemistry was apparent in all products. Attack by isopropanol as well as 
trifluoroethanol on C5 led to the isolation of undesirable side products that decreased the yield of 
the desired products (Scheme 15).71 
 




1.10.2 Deamination in late stage modification of oligosaccharides 
To show further feasibility of the oxidative deamination transformation, application to 
oligosaccharides was shown for the first time to proceed smoothly and with high 
chemoselectivity (Scheme 16).71  
 
Scheme 16. Oligosaccharide Modification by Oxidative Deamination Reaction. 
The triflate anion was also found to be a competent nucleophile in this chemistry.72 
Further, levulinic acid was shown to be a suitable nucleophile for the oxidative deamination and 
was used to functionalize the 5-postion (Scheme 17).51,52 
 
Scheme 17. Triflate and Levulinate as Nucleophiles.  
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1.10.3 Use of azide as a nucleophile in oxidative deamination. 
Oxidative deamination was very useful in the synthesis of pseudaminic acid donors. 
Traditionally, in order to introduce the azido group in a molecule, a good leaving group such as 
triflate is installed followed by SN2 displacement by an azide source such as LiN3. Interestingly, 
Zbiral’s oxidative deamination enables the introduction of the azido group with the retention of 
configuration in one step (Scheme 18).51,67,68 However, it is advisable to avoid the use of  
hydrogen azide unless in very small quantities with the appropriate safety precautions.  
 
Scheme 18. Hydrogen Azide as a Nucleophile. 
1.10.4 Oxidative deamination in aminoglycosides  
Application of the Zbiral deamination was also expanded by the Crich lab to the 
modification of aminoglycosides. Thus, Crich’s modified conditions for the oxidative 
deamination enabled  conversion of an acetamido group in an aminoglycoside derivative to the 
corresponding acetoxy group (Scheme 19).73 
 
Scheme 19. Oxidative Deamination in an Aminoglycoside.  
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1.10.5 The mechanism of oxidative deamination and substituent effects.  
The Crich lab conducted a detailed investigation of the oxidative deamination of N-acetyl 
neuraminic acid and derivatives. The protecting groups that surround the 5-postion of an N-
nitrosoacetamide were varied to the probe the reasons behind the stereo-retentive nature of the 
process. Initially, it was presumed that the acetate on the 4-position or the 7-position controls the 
stereoselectivity by neighboring group participation. However, this assumption was invalidated 
through the use of different non-participating protecting groups such as O-benzyl, tert-
butyldimethylsilyl (TBDMS), and tert-butyl ester at those positions (Scheme 20). In each case, 
substitution with retention of configuration was obtained leading to the conclusion that the ring 
oxygen participated in the stabilization of the resulting carbocation in C5, forming an oxonium 
ion intermediate followed by the equatorial substitution. Thus, the overall retention of 
configuration was observed. In Table 1, examples of deamination that have been evaluated using 
different non-participating protecting groups, are presented. Elimination products were found as 
byproducts in all examples.74 
 
Scheme 20. Crich and Buda’s Oxidative Deamination.  
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Table 1. Evaluation of Different Protecting Groups for the Deamination Reaction.  








Based on the results obtained in this study, a detailed mechanism for the oxidative 
deamination was proposed (Scheme 21). A selective N-deacetylation of N-nitrosoacetamide 74 
by trifluoroethoxide generated in situ led to the formation of the hydroxydiazine 97. Upon the 
acidification by the added nucleophile acetic acid, a subsequent protonation and removal of 
water from 97 gives the diazonium ion intermediates 98 or 99. The diazonium ion 98 is in 
equilibrium with its conjugate base diazoalkane 99. Since the media is acidic, the diazonium ion 
98 is more favored. The loss of molecular nitrogen is presumed to form one of another two 
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possible intermediates; the carbenium ion 100 and the carbene 101. The ultimate substitution 
product 103 is formed after the ring oxygen participation that stabilizes the carbocation of 100. 
The elimination byproducts are formed either directly from the diazonium ion 98 or from the 
following intermediates 100 and 101 that resulted from the loss of molecular nitrogen (Scheme 
23). 
 
Scheme 21. General Mechanism of Oxidative Deamination in the Sialic Acids. 
1.11 Overall goals  
It is necessary to establish a deeper understanding of the mechanism of the oxidative 
deamination reaction of NeuAc and its outcomes. Toward this end, it was envisaged to use 
alternative nucleophiles that are weakly acidic and less nucleophilic to probe the reactivity of the 
diazonium ion intermediates. Phenols and thiophenols were selected accordingly for this 
oxidative deamination study. Additionally, with a long term goal of developing novel sialidase 
inhibitors with which to target drug resistant viruses, the application of the deamination reaction 
for the synthesis of new generations of neuraminidase inhibitors was chosen for study. Among 
the various possible nucleophiles hydroxylamines and nitrogen-based nucleophiles were selected 
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CHAPTER 2. USE OF PHENOLS AS NUCLEOPHILES IN THE ZBIRAL OXIDATIVE 
DEAMINATION OF N-ACETYL NEURAMINIC ACID. ISOLATION AND 
CHARACTERIZATION OF TRICYCLIC 3-KETO-2-DEOXY-NONULOSONIC ACID 
(KDN) DERIVATIVES VIA AN INTERMEDIATE VINYL DIAZONIUM ION 
2.1 Background 
N-Acetyl neuraminic acid (Neu5Ac) is the most important member of the sialic acid 
family. Neu5Ac has been subjected to various modifications for chemical and biological 
purposes. The Zbiral oxidative deamination is one of the modifications that are applied to 
Neu5Ac to prepare KDN and other derivatives. In this chapter, phenols and thiophenols are 
employed as nucleophiles in the oxidative deamination of N-acetyl neuraminic acid in order to 
probe the reactivity of the diazonium ion intermediates and to provide syntheses of novel sialic 
acid derivatives that can potentially be used for medicinal applications. 
2.2 The reactivity of phenolates 
Phenols are ambident molecules whose resonance structures contain at least two sites of 
reactivity toward electrophiles (Scheme 22). The deprotonated phenol, a phenolate, has a 
negative charge delocalized on the oxygen and carbons within the ring.75 Most phenols including 
the substituted phenols, are weakly acidic with pKa values in the ranges of 7-11.  
 
Scheme 22. The Resonance Delocalization of a Phenolate.  
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2.3 The mechanistic basis of the stereo-retentive nature of Zbiral’s deamination 
As discussed in chapter 1, the Crich lab conducted a detailed study suggesting that the 
retention of configuration in the oxidative deamination of NeuAc is caused by the pyranoside 
ring oxygen participation, via a 1-oxabicyclo[3.1.0]hexanium-type intermediate (carbenium ion) 
and not by the neighboring group participation of esters.76 It is not yet clear whether the loss of 
nitrogen from the diazonium ion is concerted with participation by the ring oxygen or whether 
two steps are involved with formation of a carbenium ion as intermediate.  The final nucleophilic 
attack occurs on the equatorial face resulting in overall retention of configuration at the 5-postion 
(Scheme 23).  
 
Scheme 23. Formation and Opening of an Oxonium Ion. 
The participation of ether oxygens through comparable bicyclic oxonium ions was seen 
also in previous studies by several chemists. Thus, Corey and co-workers observed a ring oxygen 
participation during the total synthesis of glabrescol; the furanoside ring oxygen participated to 




Scheme 24. Corey’s Proposed Participation of an Ethereal Oxygen Via a Bicyclic 
Oxonium Ion. 
2.4 Formation of a 5-membered ring contracted product  
The treatment of 2-amino-2-deoxy-glucose 113 with nitrous acid led to the formation of a 
furanose through ring contraction (Scheme 25). Whereas in the absence of glycosidic oxygen 
such as in a 2-amino-1,5-anhydro sugar 118 , the deamination reaction mainly gave the product 
of substitution at C2 (Scheme 26).78 
 




Scheme 26. Substitution at C2 Through Oxygen Participation in Absence of a Glycosidic 
Oxygen. 
Similar observations were reported by Stevens,79 Hanessian,80 Horton,81 and Cassinelli82 
in several examples of pyranoside to furanoside ring contractions (Scheme 27). Moreover, 1-
thiabicyclo[3.1.0]hexanium83 and 1-azabicyclo[3.1.0]hexanium84 ions, which are equivalents to 
the ring oxygen oxonium ion, are commonly hypothesized in the literature. 
 
Scheme 27. Hexanoside to Furanoside Ring Contraction by Stevens and Co-Workers.79 
2.5 Hanessian’s observation of ring contraction   
Hanessian and co-workers obtained a furanoside from a rhamnopyranoside during an attempt at 
mesylate group displacement by the azido nucleophile (Scheme 28).85 The furanoside ring was 




Scheme 28. Furanoside Ring Contraction by Hanessian and Co-Workers. 
A related participation by sulfur was observed through the formation of 
thiabicyclo[3.1.0]hexanium ion in the synthesis of thiofuranose sugar from a thiopyranose ring. 
The two possible pathways; ring contraction or direct displacement with retention of 
configuration were suggested to take place leading to the isolation of a substituted product as 
well as a contracted thiofuranose (Scheme 29).83 
 
Scheme 29. Formation and Reactions of Thiabicyclo[3.1.0]hexanium Ions. 
2.6 Ring expansion through nitrogen participation  
Another example of the ring atom participation was reported in the synthesis of 
piperidines from prolinol derivatives. The nitrogen of the 5-membered ring prolinol participated 
to give a 1-azabicyclo[3.1.0]hexanium ion upon the departure of a β-leaving group. This was 
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followed by the nucleophile attack on the bridged carbon, leading to the rearrangement and 
expansion of the ring to form a 6-membered ring (Scheme 30).84 
 
Scheme 30. Nitrogen Participation Followed by Ring Expansion. 
2.7 Synthesis and isolation of alkenediazonium ions  
Although alkenediazonium ions are very reactive compounds and not isolable in the form 
of free ions, they have been isolated under harsh acidic conditions as hexachloroantimonate salts. 
Bott has reported the synthesis of series of the alkenediazonium ions with the use of strongly 
acidic reagents for the formation of resonance-stabilized salts.86 The reaction between ethyl 
diazoacetate and triethyloxonium hexachloroantimonate in ethylene dichloride provided 
colorless crystals of an alkenediazonium salt in 50% yields; it was characterized by elemental 
analysis as well as infrared spectroscopy in which a sharp peak was observed near 2160 cm-1, 
which was considered supportive of the presence of a diazo group (N≡N) (Scheme 31).86,87 
 
Scheme 31. Formation of an Alkenediazonium 144 Ion from Ethyl Diazoacetate 143.  
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Subsequently Glaser was able to obtain an X-ray structure of β,β-diethoxyethene 
diazonium hexachloroantimonate 144, thereby putting the existence of this rare functional group 
beyond question (Figure 8).88,89 
 
Figure 8. Literature X-Ray of Alkenediazonium Ion 144.88 
Some other stable alkenediazonium salts were isolated by the treatment of hydrogen 
chloride, and antimony pentachloride with methyl benzoyldiazoacetate or its derivatives in 
dichloromethane to provide the alkenediazonium salts as crystalline compounds 146 and 147. 
The formation of an intramolecular hydrogen bond and the non-nucleophilic 
hexachloroantimonate counter ion stabilizes this kind of alkenediazonium ion of 147 (Scheme 
32).86,87 
 
Scheme 32. Isolation of Alkenediazonium Salts from Benzoyldiazoacetates.  
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Additionally, alkenediazonium salts can be synthesized by the treatment of 2,2-
dichlorovinyl isocyanate 148 with nitrosyl hexachloroantimonate in dichloromethane. The 
product 149 was formed in a 40% yield (Scheme 33).86 Mechanistically, the reaction proceeds in 
two steps; N-nitrosation of 2,2-dichlorovinyl isocyanate, followed by the release of CO2 gas.  
 
Scheme 33. Synthesis of Alkenediazonium Salt 149 from Dichlorovinyl Isocyanate 148. 
The preparation of alkenediazonium salts can also be achieved over two steps, by the 
treatment of a β-chloro-sulfonylhydrazone 150 with acids such as AlCl3, SbCl5 and SnCl4.
90 The 
use of two equivalents of  the acid is required to i) eliminate the halide, and ii) to facilitate the 
departure of tosylate group, leading to the formation of alkenediazonium salt 152 (Scheme 34).86 
 
Scheme 34. Preparation of Alkenediazonium Salt 150 from Sulfonylhydrazone. 
2.8 Reactivity of diazonium ions 
Diazoalkanes are an important class of diazo compounds that have wide applications in 
organic synthesis. They have two resonance forms giving rise to the possibility of nucleophilic 




Scheme 35. Resonance of Diazomethane. 
α-Protonation of diazoalkanes forms the corresponding diazonium ions, which are 
sources of carbocations (Scheme 36). Diazomethane is the simplest member of the diazoalkanes, 
and it is converted by protonation to the methyldiazonium 155 ion so that it acts as a methylating 
reagent under acidic conditions in organic synthesis.91,92 However, the extreme reactivity of 
diazomethane disfavors its utilization in synthetic labs because it is toxic and potentially 
explosive.93 Although the methyldiazonium ion 155 is very reactive and unstable, it was 
observed along with its protonated isomer methylene diazenium ion 156, by a low temperature 
NMR at -106 °C in fluorosulfuric acid at - 120 °C (Scheme 37).94 
 
Scheme 36. α-Protonation of Diazomethane. 
 
Scheme 37. Observation of Methyldiazonium ion 155 by a Low Temperature NMR.  
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2.9 Oxidative deamination using phenols and thiophenols  
2.9.1 Synthesis of the substrate for deamination  
The synthesis of methyl (methyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-5-(N-
nitrosoacetamido)-D-glycero-β-D-galacto-non-2-ulopyranosid)onate 74 was reproduced as 
reported in the literature76,95 from  the commercially available N-acetyl neuraminic 1. Thus, 
compound 1 was treated with an acid source (Amberlyst® 15 hydrogen form) in anhydrous 
methanol to O-methylate the anomeric hydroxyl and the carboxylic acid group leading to methyl 
ester 157 in quantitative yield. This was followed by a global acetylation of the remaining 
hydroxy groups to furnish a per-acetylated N-acetyl neuraminic acid 158 in 91%. The N-nitroso 
compound 74 was obtained in a quantitative yield through N-nitrosylation by the treatment of 
per-acetylated N-acetylneuraminic acid 158 with nitrosyl tetrafluoroborate (NOBF4) and pyridine 
in dichloromethane at – 10 C. Compound 74 typically was used immediately without further 
purification for the oxidative deamination (Scheme 38). 
 
Scheme 38. The Synthesis of the Starting Material 74 for the Deamination Reactions. 
The conditions of the deamination used here were adapted from the previous work76 by 
the treatment of the nitrosoamide 74 with sodium trifluoroethoxide in the presence of 18-crown-
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6 in anhydrous dichloromethane at – 10 C, followed after 10 minutes by an excess addition of  
phenolic nucleophile.  After stirring for a further 5 minutes, the reactions were quenched by 
aqueous sodium bicarbonate, washed with aqueous sodium hydroxide to remove the excess of 
the nucleophile, and then subjected to chromatographic purification to afford series of the 
deaminated products (Table 2).  
2.10 Results  
Levulinic acid with a pKa of 4.6096 was used as a carboxylic acid nucleophile to establish 
the viability of the reaction conditions: it provided the direct substitution product 159 with 
retention of configuration in a 31% isolated yield. In addition to that, the regioisomeric 
elimination products 160 and 161 were isolated as byproducts in a 34% combined yield (Table 
2, entry 1). The use of phenol as nucleophile led to the isolation of the disubstitution product 
162, in which the acetate substituent at C4 was displaced by phenol with the retention of 
configuration in addition to replacement of the nitrosoamide moiety at the 5-position with 
inversion of configuration (Table 2, entry 2).  Additionally, enol ether 163 was isolated from this 
reaction in a 31% yield as byproduct.   
The use of β-naphthol as nucleophile gave the tricyclic product 164 in a 57% yield 
accompanied by the azo dye 165 in a 13% yield (Table 2, entry 3).  
The use of p-methoxyphenol afforded a 36% yield of the enol ether 166 (Table 2, entry 
4), whereas that of p-nitrophenol gave a 9% yield of the direct substitution product 167 at 5-
position and a 9% yield of the elimination enol ether product 168 (Table 2, entry 5).  The use of 
a disubstituted electron-rich phenol such as 3,5-dimethoxyphenol, on the other hand, provided 
the tricyclic adduct 169 in a 34% yield (Table 2, entry 6). 
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Turning to the use of heteroaromatic phenols as nucleophiles, the use of 2-quinolinol 
afforded only the elimination products 160 and 161 in a 86% combined yield (Table 2, entry 7), 
whereas 3-quinolinol gave the elimination enol ether products 170 and 171 in  21% and  12% 
yields, respectively (Table 2, entry 8).  With the use of 6-quinolinol, on the other hand, similar 
reactivity was detected as that of β-naphthol and 3,5-dimethoxyphenol. This led to the isolation 
of the tricyclic product 172 in a 53% yield (Table 2, entry 9).  This latter reaction was conducted 
in the poorly nucleophilic hexafluoroisopropanol97,98 as a co-solvent to dissolve the nucleophile 
because the solubility of the nucleophile in dichloromethane was very limited. The same pattern 
was observed with 5-hydroxyindole leading to the isolation of the tricyclic product 173 in a 3% 
yield when the reaction was performed at −10 °C (Table 2, entry 10), and in a 27% yield when 
the reaction temperature was lowered to − 40 °C (Table 2, entry 11).  The formation of 173 was 
accompanied by that of the normal elimination products 160 and 161 in 35% and 7% combined 
yields at −10 and − 40 °C, respectively (Table 2, entries 10 and 11), while a 9% yield of the azo 
dye 174 was also isolated from the reaction at the lower temperature (Table 2, entry 11).  
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Table 2. Application of Phenols in the Zbiral Reaction. 
 
Entry Nucleophile pKa Products (% yield)a 























































a) The elimination products were the side products in all deamination reactions and were not 
isolated in every reaction. b) Hexafluoroisopropanol was used to dissolve the nucleophile. c) the 
reaction was conducted at – 40 C.  
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2.10.2 Thiophenols as nucleophiles  
Attention was next turned to the use of thiophenols as nucleophiles. The typical 
substitution product 175 was isolated in a 23% yield with retention of configuration (Table 3, 
entry 1). This product was accompanied by the reduction product 176 in a 19% yield. On the 
other hand, the use of 2-aminothiophenol provided a 58% of the direct substitution product 177, 
but as a mixture of isomers; 3:1 axial:equatorial (Table 3, entry 2), along with the reduction 
product 176 in a 20% yield. Finally, the use of 2-mercaptonaphthalene as nucleophile afforded 
the substitution with retention of configuration product 178 in a 30% yield, contaminated with a 
minor amount of the stereoisomer 178a in a 25% yield, and the reduction product 176 in a 13% 
yield (Table 3, entry 3). 
Table 3. Application of Thiophenols in the Zbiral Reaction. 


















a) The elimination products were the side products in all deamination reactions and were 
not isolated in every reaction. 
2.12 Structural elucidation 
2.12.1 NMR data of the disubstituted and unusual tricyclic products  
The structures of 159, 167, 175, 176, 177, and 178 that were obtained from the direct 
substitution reaction, can be clearly characterized and confirmed by NMR analyses. However, 
the unexpected deamination products that resulted from either substitution-elimination or from 
solely elimination process in this reaction are worthy of further explanation. The disubstitution 
product 162 that resulted from using phenol as nucleophile, was characterized mainly by 1H-
NMR with the focus on the measured data obtained from the 3JH,H coupling constants as well as 
nOe contacts that surround the pyranose ring (Figure 9). 
 
Figure 9. nOe Correlation in the Disubstitution Product 162. 
 The 3JH4,H5 and 
3JH5,H6 coupling constants of 4.5 and 2.0 Hz, respectively, were recorded 
in C6D6 due to the overlap of H’s 5 and 6 in CDCl3 in the structure of 162. On the basis of these 
coupling constants, the substituents at C’s 4, 5, and 6 were found to be in a cis-relationship. 





Figure 10. 1H NMR Recorded in C6D6 of the Disubstitution Product 108. 
 
Figure 11. nOe Difference Spectrum of the Disubstitution Product 162 Obtained by 
Double Irradiation of H4.  
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2.12.2 The X-ray data for the tricyclic product 164 
The tricyclic product 164 was crystallized from diethyl ether and its structure was 
determined by X-ray crystallography (Figure 12). Upon inspection of this crystal structure, the 
pyranose ring approximately was found to adopt a 3,6B boat conformation (Table 2, entry 3).  
 
Figure 12. X-Ray Crystallographic Structure of Product 164 (CCDC 1941624). 
This 3,6B conformation also predominates in solution as indicated by the ensemble of 3J 
scalar couplings in the H3a,b, H4, H5, H6 spin systems (Table 4) as well as by nOe interactions 
that were measured between one of the H3 protons and an aromatic proton (Figure 13 and 14). 
 




Figure 14. nOe Difference Spectrum of Tricyclic Product 164 on Double Irradiation of 
the Pseudoequatrial H3. 
Although the tricyclic product 164 adopted a boat conformation, its side chain retains the 
conformation commonly found in NeuAc and its derivatives. Thus, the side chain of the tricyclic 
product 164 was found to adapt the gauche,gauche-conformation (gg),103,104 ,which is similar to 
that found in the N-acetyl neuraminic acid (Figures 15 and 16).105-111  
 




Figure 16. NeuAc and the Tricyclic Compound 164 Side Chain Conformations. 
In addition, the disubstitution  product 162 most likely does not adopt the gg-
conformation because the axial phenoxy substituent at C5 with 3J6,7 of ~ 2.0 Hz, forces the side 
chain to deviate from its original gg-conformation to a different conformation, along with the 
adopting of the standard 2C5 chair conformation in 162.
105-111 The strong dipolar and steric (syn-
pentane) type interactions (Figure 17) are obviously present in between the C5-O5 and C7-O7 
bonds in this conformation 162 (Figure 17). Thus, the side chain in this compound 162 takes up 
a different conformation in order to relieve the strain and the steric interaction (Figure 17).112 
 
Figure 17. Demonstration of Syn-Pentane-Type Interaction and Its Influence on the Side 
Chain Conformation of 162.  
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The tricyclic structures 169, 172, and 173 were assigned by analogy with 164 on the basis 
of NMR studies, with their coupling constants in the H3a,b, H4, H5, H6 spin system being very 
similar to those of the product 164 (Table 2).  In each of the tricyclic products 164, 169, 172, 
and 173 the 3J coupling constant between the pseudo-axial H3 and H4 is found to be at the upper 
limit of the normal range (12.9-13.5 Hz) observed for a pair of coupled trans-diaxial spins in 
saturated aliphatic systems, presumably because there are no electronegative substituents in this 
spin system (Table 4).113 
Table 4. Chemical Shifts and Diagnostic Coupling Constants for 162, 164, 169, 172, and 173.a 
 chemical shifts (δ, ppm)b coupling constants (Hz) 







162 2.55 2.47 4.52 3.14 3.13 4.99 8.9 3.2 3.7 - 5.3 14.9 
162c 2.77 2.57 4.61 3.01 3.18 5.16 8.8 3.4 4.5 2.0 5.7 14.8 
164 1.90 2.86 3.87 4.94 4.21 5.69 13.5 5.0 9.2 9.4 5.1 14.9 
169 1.79 2.63 3.47 4.70 4.03 5.59 12.9 5.4 9.1 9.4 4.6 14.9 
172 1.92 2.78 3.88 4.99 4.21 5.68 13.4 5.1 8.9 9.3 5.0 14.9 
173 2.02 2.72 3.77 4.82 4.12 5.67 12.8 5.5 8.8 9.4 5.0 14.9 
a) All spectra were recorded in CDCl3 unless otherwise stated. b) H3pa and H3pe mean pseudo-
axial and pseudo-equatorial protons at C3, respectively. c) Recorded in C6D6.  
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2.12.3 Elucidation of structure of the enol ethers by chemical methods  
Two possible regioisomeric structures for enol ethers 163, 166, and 170 could not be 
distinguished by normal 1H and 13C NMR spectroscopic methods because of the ambiguity in the 
multiplicity of the long range coupling constants around the pyranose ring. Therefore, it was 
unclear whether the nucleophile had attacked at the 4- position or the 5-position (Figure 18).  
 
Figure 18. Ambiguous Long Range Couplings in The Possible Enol Ether Products 179 
and 166. 
Eventually, a chemical reaction enabled to correctly assign the enol structures. Using 166 
as a demonstrative example; it was treated with ethylene glycol in dichloromethane in the 
presence of p-toluenesulfonic acid at room temperature, and the cyclic ketal 180 was isolated in a 
42% yield (Scheme 39). The two methylene spin systems in this ketal clearly indicate that the 
structure was 180 and not the other alternative ketal 181. Thus, compound 166 was the product 
resulting from the deamination process and not the other presumed product 179. Further, the 
structure of 166 was confirmed by the treatment with ethylene glycol and p-toluenesulfonic acid 
in wet methanol at room temperature when the enone 182 was isolated in a 55% yield (Scheme 





Scheme 39. Chemical Elucidation of Enol Ether 16. 
With the structure of 166 in hand, the full complement of long range couplings in this 
product could be assigned (Table 5). 
Table 5. Chemical Shifts and Coupling Constants for 166. 
 chemical shifts (δ, ppm) coupling constants (Hz) 







166 2.53 2.64 - 4.51 4.45 5.23 2.0 2.5 - 1.9 5.3 17.1 
The azo dyes 165 and 174 have intense yellow colors, which are typical of such 
derivatives. Their structures were further confirmed by 1H and 13C NMR, UV/visible spectra, and 
high resolution mass spectrometry (HRMS). Accordingly, NMR analysis showed that the diazo 
group (N=N) connects the 5-position of NeuAc with the C2 of β-naphthol moiety in the structure 
165 as well as with the C4 of 5-hydroxyindole moiety in the azo dye 174. Moreover, the 
aromatic protons in C2 of β-naphthol and in C4 of 5-hydroxyindole, which are distinct peaks in 
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1H NMR, have disappeared but the remaining aromatic protons were clearly assigned in the both 
azo dyes. UV/Visible spectroscopy showed absorbance peaks at λmax 380 nm and λmax 365 nm for 
165 and 174, respectively. Finally, the retention of the azo moiety in both structures was 
confirmed by HRMS (Table 6 and Figure 19). 
Table 6. Characterization Data of the Diazo Dyes.  
Azo dye  UV/Visible spectra  Molecular formula  HRMS 
165 λmax 380 nm (acetonitrile, ε = 8699 M
-1 cm-1) C29H34N2O13Na 641.1964 
174 λmax 365 nm (dichloromethane, ε = 2391 M





Figure 19. 1H NMR of the Azo Dyes. 
2.12.3 Determination of the configuration at the 5-position  
The retentive nature of the configuration is confirmed by the measurement of the 
coupling constants of the protons residing in C4, C5 and, C6. When the substituent (nucleophile) 
at C5 is equatorial, the coupling constant of the axial proton is in between ~ 8-11. On the other 
hand, if the substituent is axial and the proton is equatorial, the coupling constant is 
approximately ~ 2-3. The structure 174 is shown as an example in (Figure 20) to determine the 




Figure 20. Determination of the Stereochemistry of H5 by Measuring the Coupling 
Constant. 
2.13 Discussion  
The ensemble of results may be explained according to the formation and reactions of a 
diazonium ion intermediate. Upon the addition of sodium trifluoroethoxide, the N-acetyl group is 
selectively removed from the acetamido moiety leading to the formation of hydroxydiazine 97a. 
The protonated hydroxydiazine 97a loses water after a second protonation, to form the 
diazonium ion 98. It is suggested that the diazonium ion 98 undergoes reversible deprotonation 
to form its conjugate ion diazoalkane 99, and both ions are in equilibrium. Depending on the 
acidity of the media, one of these two intermediates can predominate over another. Additionally, 
the formation of the azo dyes 165 and 174 is a strong evidence that the diazonium ion is involved 
as an intermediate in this process (Table 2). 
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The reversible deprotonation of the diazonium ion was previously confirmed by the Crich 
lab through the use of deuterioacetic acid as nucleophile. This led to the selective installation of a 
deuterium atom in the 5-position and formation of monodeuterio-KDN derivative (Scheme 40).76  
 
Scheme 40. The Incorporation of Deuterium at the 5-Position by the Crich Lab. 
 The diazonium ion 98, which has electron withdrawing and acidity-enhancing β-C−O 
bonds, is expected to be more acidic than the simple methyldiazonium ion114 (pKa ∼ 10). In 
more acidic media, diazonium ion 98 is favored over the diazoalkane 99 leading to the loss of 
nitrogen followed by the formation of the standard substitution and normal elimination products 
(Scheme 41).  In less acidic reaction media, such as that of phenols employed here, the 
diazoalkane 99 is formed and undergo β-elimination of the acetoxy group from the 4-position to 




Scheme 41. Overall Mechanism for Product Formation. 
The normal elimination products that are regularly isolated in the oxidative deamination, 
are formed either directly by the loss of the molecular nitrogen from the diazonium ion followed 
by β-elimination or from the N-nitrosoacetamide 74 through the elimination by the anionic 
oxygen of the nitroso moiety (Scheme 42). 
 
Scheme 42. The Formation of Elimination Products. 
2.13.1 The formation of disubstitution product 162 
The vinyl diazonium ion in this reaction is a reactive electrophile that can populate two 
possible half-chair conformers 186-OH2 and 186-2HO and related boat conformers (Scheme 42). 
β-Face attack, occurs on the conformer 186-2HO under kinetic Michael addition leading to the 
formation of a new chair structure of diazoalkane 188. On the other hand, the nucleophile attack 
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from the bottom-face under thermodynamic Michael addition fashion leads to the equatorial 
delivery and formation of the chair conformation 187 (Scheme 42).  
In the case of phenol as nucleophile, thermodynamic attack is followed by the 
protonation of the diazoalkane, and another molecule of phenol comes into play on the α-face 
leading to a contact ion pair (CIP) 190. This loses the molecular nitrogen and forms the isolated 
product 162 with inversion of configuration (Scheme 43). Protonation of 189 from the α-face is 
also consistent with the earlier work by the Crich lab using the deuterium-labeling experiments 
(Scheme 40).76 Finally, the enol ether 163 is formed from 190 by the loss of nitrogen followed 
by deprotonation in concerted fashion (Scheme 43). 
A similar pathway of elimination was observed for p-methoxyphenol and 3-quinolinol 
leading to the enol ethers 166, 170, and 171 as major products (Table 2, entries 4, 5, and 8). On 
the other hand, with the more acidic p-nitrophenol as nucleophile, the reprotonation of the 
diazonium ion 98 is competing with the elimination. Thus, the direct substitution product 168 is 
formed in minor quantity (Table 2, entry 5). 
 
Scheme 43. Formation of Disubstitution Product 162.  
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2.13.2. The formation of tricyclic product 164 
In the case of β-naphthol, which is an ambident nucleophile, the kinetic Michael addition 
takes place and the intermediate 191 is trapped by intramolecular proton transfer leading to the 
formation of zwitterion 192. The tricyclic product 164 is then formed by the ring closure of the 
zwitterion by the nitrogen displacement at C5 (Scheme 44). 
 
Scheme 44. Formation of Tricyclic Product 164. 
2-Quinolinol is very weakly nucleophilic and no substitution product was observed 
because it exits mostly as quinolinone (Scheme 45). The normal regioisomeric elimination 
products are the only isolated products 160 and 161 of this reaction (Table 2, entry 7). 
 
Scheme 45. The Tautomeric Forms of 2-Quinilinone. 
2.13.3 Mechanism of reaction with thiophenols as nucleophile  
Because thiophenols are more acidic than phenols, the acidity of the reaction media is 
increased and diazonium ion 98 predominates over the diazoalkane 99. Thus, the direct 
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substitution products are isolated with the retention of configuration (Scheme 46). However, 
minor amounts of the axial substitution products were observed with the inversion of 
configuration due to the direct displacement of nitrogen by the sulfur atom nucleophile, which is 
competitive with ring oxygen participation. 
 
Scheme 46. Formation Equatorial and Axial Substitution in Thiophenols. 
The reduction product 176 is formed possibly through a single electron transfer (SET) 
process. The diazonium ion 98 losses molecular nitrogen and receives a single electron from the 
thiophenolate to form alkyl radical 198, which is converted to the reduction product 176 after 
hydrogen atom transfer (HAT) from another molecule of thiophenol.  Alternatively, 
thiophenolate couples with the terminal nitrogen of the diazonium ion 98 to afford 
arylthiodiazene 197, followed by homolytic scission to provide the alkyl radical 198 and 
followed, by HAT that leads to the reduction product 174 (Scheme 47). This reduction process is 
consistent with the proposed mechanism reported in the literature for the reduction of 
arenediazonium ions by thiophenols.115 The formation of the reduction product therefore further 




Scheme 47. Mechanism for the Formation of the Reduction Product 176. 
2.14 Conclusion  
The use of phenols and thiophenols as nucleophiles in the oxidative deamination has led 
to the discovery of a new branch of the Zbiral-type deamination reaction through the formation 
of a vinyl diazonium ion, a member of the little-studied class of alkenediazonium ions. The 
formation of different types of deamination products is a function of the acidity of the reaction 
media. More acidic media such as with thiophenols tend to favor the direct substitution products, 
while less acidic solutions lead to the formation of an electrophilic vinyl diazonium ion and, 
following Michael addition, disubstitution products. 
57 
 
CHAPTER 3. THE ISOLATION AND CHARACTERIZATION OF NOVEL 
NEURAMINIC ACID DERIVATIVES FROM THE USE OF HYDROXYLAMINES AND 
RELATED COMPOUNDS AS NUCLEOPHILES IN THE ZBIRAL OXIDATIVE 
DEAMINATION OF N-ACETYL NEURAMINIC ACID 
3.1 Background  
3.1.1 Overview 
Hydroxylamines are an under-appreciated functional group whose derivatives may be 
useful for pharmacological applications.116 Hydroxylamines have been found to play a 
significant role in the immunogenic activity of mycobacterial ribonucleic acid vaccines in 
mice.117 It was described that hydroxylamine derivatives may function as antifungal, antiviral 
and antifungal agents.118  Oximes and hydroxamic acids are related structures derived from 
hydroxylamine (Figure 21). 
 
Figure 21. Structures of Hydroxylamines, Hydroxamic Acids and Oximes. 
 The hydroxamic acids are an important class of chemical compounds that are utilized in 
a wide range of biological and medicinal applications. For instance, the structures of hydroxamic 
acids mimic some functional groups that are present in protein structures.119 Molecules 
containing a hydroxamic acid moiety are found to potentially function as inhibitors of 
Helicobacter pylori urease.120 Both the oxygen and the nitrogen atoms in hydroxylamines and 
their derivatives, carry lone pairs, and so are potentially nucleophilic sites that can react with 
electrophiles.121 These (N−OH)-containing organic molecules are weakly acidic and their pKa 
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values vary according to the substituents connected to nitrogen as well as the ability to release a 
proton from the terminal hydroxy group (Figure 22).122-125 
 
Figure 22. Examples of Hydroxylamine Derivatives and Their pKa Values. 
One of the properties that accompanies these molecules is the α-effect, which describes  
the increase in nucleophilicity of molecules with two covalently bonded heteroatoms, which 
occurs due to the presence of lone pairs on adjacent atoms.126  
The hydroxamic acid function has two possible acidic sites; hydroxyl O-H and amine N-
H moieties, and a basic site in the form of the carbonyl oxygen. A hydroxamic acid can exist in 
two structures E and Z, but the Z structure is more stable due to the formation of a hydrogen 
bond between the oxygen of the carbonyl group and the proton of the hydroxy group.122 A 
hydroxamic acid can also exist in two tautomeric forms in a keto-enol like equilibrium (Scheme 
48).126,127  
 
Scheme 48. Hydrogen Bond Stabilization and Tautomerism of Hydroxamic acids.  
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3.2 Research goal  
As discussed in chapters 1 and 2, the oxidative deamination is a useful method to 
functionalize the 5-position of N-acetyl neuraminic acid with various nucleophiles and protecting 
groups. Accordingly, hydroxylamines, hydroxamic acids, oximes, nitrogen heterocycles and 
amines with variable pKa values, were screened as nucleophiles in the oxidative deamination of 
NeuAc to probe their reactivities and eventually probe the resulting products for potential use as 
sialic acid-based neuraminidase inhibitors. 
3.3 Results 
The substrate 74 for the oxidative deamination was prepared according to the method 
reported in chapter 1. This nitrosyl sialoside 74 was treated with sodium trifluoroethoxide and 
18-crown-6 in anhydrous dichloromethane at – 10 C. Hydroxylamine, hydroxamic acid, or 
nitrogen-based nucleophiles were then added in the next step to afford the deaminated products 
(Scheme 49).  
 
Scheme 49. Synthesis and Deamination of Nitrosyl Sialoside 74. 
Most nucleophiles in this study were purchased from commercial suppliers and were used 
in the deamination reactions without further purification. But, N-(p-
methoxybenzyl)acetohydroxamic acid was prepared from 4-anisaldehyde by reproducing the 




Scheme 50. Preparation of N-(p-Methoxybenzyl)acetohydroxamic Acid 
 N-Boc-Acetohydroxamic acid was prepared by following a literature protocol; it was 
synthesized from di-tert-butyl dicarbonate and hydroxylamine hydrochloride giving 203, which 
was then acetylated using acetyl chloride (Scheme 51).129  
 
Scheme 51. Preparation of N-Boc-Acetohydroxamic Acid. 
3.3.1 Deamination Reactions  
 1-Hydroxybenzotriazole (HOBt) was the first nucleophile used in this study. This 
nucleophile gave the direct substitution product 205 with the retention of configuration in a 48% 
yield (Table 7, entry 1). Similarly, the use of N-hydroxysuccinimide (NHS) as nucleophile, 
provided the direct substitution product 206 at C5 with the retention of configuration in a 36% 
yield (Table 7, entry 2).  
The use of N-hydroxyphthalimide (NHPI) as nucleophile, on the other hand, provided 
two deamination products; a mono-substitution product 207 at C5 isolated in a 36% yield, and a 
disubstitution product 208 at both C4 and C5 isolated in a 27% yield. These two products were 
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accompanied by the normal mixture of elimination products 160 and 161 in 23% yields and a 
1:2.5 ratio (Table 7, entry 3).  
The use of N,N-diethylhydroxylamine afforded only the normal elimination products 160 
and 161 in a 36% yield; no substitution product was observed (Table 7, entry 4).  
Attention was next turned to hydroxamic acids as nucleophiles. Acetohydroxamic acid, 
with a pKa of 9.40,130 gave a novel bicyclic disubstitution product 209 at both the 4- and the 5-
postions in 21% yield, accompanied by a single isomer of elimination product 161 in a 28% 
yield (Table 7, entry 5). In addition, a product 210, possibly corresponding to a direct 
substitution on C5 by acetohydroxamic acid nucleophile, as determined by mass spectroscopy 
(Figure 23), was isolated in a 30% yield, but was found by 1H NMR spectroscopy to be an 
inseparable mixture of at least three products. Presumably, this mixture 210 arose because 
acetohydroxamic contains multiple forms of isomers resulting from tautomerism and keto-enol 
interconversion.127 Unfortunately, it was not possible to separate this mixture and so the exact 
structures of the compounds could not be determined.   
 
Figure 23. High Resolution Mass Spectroscopy for the Mixture 210 with 544.1647 m/z.  
62 
 
The hydroxamic acid derivatives; N-(p-methoxybenzyl)acetohydroxamic acid and N-
Boc-acetohydroxamic acid (Table 7, entries 6 and 7), together provided the novel 4-deoxy-5-
desacetamido non-4-eneulosonic acid derivative 211, in 21% and 10% yields, respectively. 
Access to this type of alkene was only previously reported by Takahashi and coworkers when 
they constructed an unusual NeuAc derivative for the purpose of synthesizing gangliosides from 
GM3 intermediates.
131 In both reactions (Table 7, entries 6 and 7), this alkene product 211 was 
accompanied by the elimination products 160 and 161 as side products in 18% and 41 % yields, 
respectively. With N-Boc-acetohydroxamic acid additional side products, the ketone 212 and 
enone 213 were formed as an inseparable and mixture isolated in 17% combined yield (Table 7, 
entry 7).  
 The oximes were examined starting with the use of p-nitrophenylbenzaldehyde oxime as 
nucleophile. Substitution at C4 was found to occur leading to the isolation of vinyl ether 214 in 
26% yield, accompanied by an inseparable mixture of ketone 212 and enone 213 in 8% 
combined yield (Table 7, entry 8). On the other hand, acetone oxime was not effective as 
nucleophile for this oxidative deamination, and only the products of elimination 160 and 161 
were isolated in a 38% yield (Table 7, entry 9).  
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Table 7. Oxidative Deamination Using Hydroxylamines Hydroxamic acids and Oximes. 
 



















































a) The elimination products were the side products in all deamination reactions and were not 
isolated in every reaction. 
Attention was next shifted to the use of nitrogen nucleophiles. The use of aniline as 
nucleophile provided the aziridine 215 in a 49% yield (Table 8, entry 1). This reaction 
additionally produced a triazoline 230 as intermediate, detected by mass spectroscopy, which 
decomposed during the workup and/or in the process of the chromatographic purification. 
Alternatively, stirring the crude mixture of this latter deamination at room temperature for 
additional time (20-30 minutes), led to the intermediate triazoline 230 to convert to the aziridine 
product 215 with enhanced yield of 56%. 
Attempted use of 3,5-dimethylpyrazole as nucleophile, gave a complex mixture and none 
of the desired substitution products were isolated. In this reaction, 3,5-dimethylpyrazole was 
insoluble in the optimal dichloromethane, and therefore, HFIP was used as a co-solvent. HFIP is 
known to be a practical reagent for dissolving organic compounds that are insoluble in typical 
organic solvents; it is weakly nucleophilic, but acidic with pKa of 9.3.97,98,136-138 However, a 
novel disubstituted product 216 was isolated in a 9% yield (Table 8, entry 2). This product 
resulted from the attack of two molecules of hexafluoroisopropanol (HFIP) at both the 4- and the 
5-positions. 
Finally, nitrogen-based heterocycles such as indole, 2-pyridone and N-hydroxypyridone-
2-thione were surveyed as nucleophiles; each of them provided only a mixture of inseparable 
elimination products 160 and 161, isolated in 80%, 32%, and 12% yields, respectively (Table 8, 
entries 3, 4, and 5). 
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Table 8. Oxidative Deamination Using Nitrogen-Based Nucleophiles. 
 





























a) The elimination products were the side products in all deamination reactions and were not 
isolated in every reaction. b) Hexafluoroisopropanol was used to dissolve the nucleophile. 
3.3.2 Structural elucidation of products 
 The deamination using HOBt as a nucleophile in principle could give two 
possible structures 205 and 218 since HOBt is an ambident nucleophile that can attack via 
oxygen or nitrogen. The product 205 was assigned as the correct structure following chemical 
confirmation by the treatment with zinc and acetic acid in refluxing tetrahydrofuran for 2 hours. 
Under these conditions, the N-O bond was cleaved and the KDN derivative 217 was observed in 
a quantitative yield. This product 217 was then acetylated by the treatment with acetic anhydride 
and pyridine, and the peracetylated KDN 75 was isolated with the retention of configuration in a 
97% overall yield (Scheme 52). This method was previously reported in the literature for 
cleaving a N-O bond.136 Thus, the alternative attack by the nitrogen of HOBt did not occur and 
the structure 218 was excluded. 
 
Scheme 52. Probing Compound 205 and Formation of KDN Derivative 75.  
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The structures of the direct substitution products 205, 206 and 207 were assigned by 
NMR data based on the analysis of chemical shift and coupling constants. These products are 
consistent with the retention of configuration at C5 as previously discussed in chapter 2. The 
structures were confirmed by the measurement of the 3JH4,H5 coupling constants of H5’s giving 
9.7, 9.7 and 9.4 Hz for the products 205, 206 and 207, respectively. Thus, H5 in all structures 
205, 206 and 207, is in trans-relationship with both H4 and H6 with large 3JH5,H6 coupling 
constants 10.1, 9.7, and 9.8, respectively.  
 
Figure 24. The Structures Derived by Direct Substitution with Retention of 
Configuration. 
The alkene structure 211 was simply assigned from its 1H and 13C NMR data, whereas 
structures 160, 161 and 214 had spectral data that matched with the previously reported products 
of oxidative deamination from chapter 2.  
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3.3.3 Structural analyses of compounds 208, 209, 215 and 216 
Products 208, 209, 215, and 216 displayed interesting structural variations, which were 
confirmed by careful NMR analyses. The disubstitution product 208 arose from the double 
substitution with retention of configuration on both the 4- and the 5-positions. According to the 
1H NMR spectrum of 208, the 3JH3e,H4, 
3JH3a,H4, and 
3JH4,H5 coupling constants are 10.5, 5.5, and 
8.0 Hz , respectively, indicating that 208 is in the typical 2C5 chair conformation with the all-
trans configuration (Table 8). Further, the 3JH5,H6 coupling constant of 9.6 Hz, which is large, 
indicates that the H5 and H6 are in a 1,3-trans-diaxial relationship, which clearly matches the 
chair conformation (Figure 25). 
 
Figure 25. Configuration and Chair Conformation of Product 208. 
The structure of the bicyclic 209 most likely adopts the 2C5 chair conformation carrying 
cis 4,5-disubstituents that comprise a heterocyclic ring. The configuration and conformation of 
209 were deduced by study of the coupling constants in the H3’s, H4, H5 and H6 spin system as 
well as from nOe correlations (Table 8). The 3JH3e,H4, 
3JH3a,H4 coupling constants are 2.5 and 4.2 
Hz, respectively. Further, the small value ~ 2.7 Hz for the 3JH4,H5 coupling constant suggests that 
both H4 and H5 are in a cis-relationship. In addition, the 3JH5,H6 coupling constant is ~10.0 Hz, a 
large value that is indicative of the trans-vicinal relationship (Figure 26). nOe contacts exist 
between H5 and H3 as well as H5 and H7. Further confirmation of the structure 209 was proved 
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by inspection of the HMBC spectrum, which shows that the imidate carbonyl carbon correlates 
with H5 (Figure 27), so eliminating from consideration the alternative structure 219 (Figure 26). 
 
Figure 26. Key nOe and HMBC Correlations in Compound 209, and the Alternative 
Structure 219. 
 
Figure 27. Three Bonds Correlations in HMBC Between H5 and the Imidate Carbonyl for 209. 
 The aziridine 215 takes up a 3,6B boat conformation according to the NMR analyses as 
well as comparison with the corresponding 2-naphthol-derived tricyclic 164 that was confirmed 
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by X-ray crystallography. The newly formed 3-membered ring in the structure 215 is cis-fused 
across C4 and C5, and the N-phenyl group is exo to the bicyclic nucleus. This was confirmed by 
nOe contacts found between both H4 and H5 and the aromatic ortho-protons of the phenyl ring. 
Further, nOe correlation was also observed between H5 and H7 of the side chain. The 3J(CH4, CH5) 
coupling constants of 7.0 Hz for the α-protons of H4 and H5, indicate that they are in cis-
relationship (Figure 28). 
 
Figure 28. nOe Interactions and the H4-H5 Vicinal Coupling of the Aziridine 215. 
Finally, the configuration and conformation of the hexafluoroisopropanol adduct 216 are 
established by analysis of NMR coupling constants and nOe correlations.  Thus, 3JH4,H5 at 8.2 Hz 
indicates that H’s 4 and 5 are either close to antiperiplanar or synperiplanar, while the 3JH3ax,H4, 
3JH3eq,H4, and 
3JH5,H6 coupling constants of 6.1, 3.2, and 2.1 Hz, respectively, exclude axial 
orientations for both H4 and H5 (Table 8). This ensemble of information points to a chair-like 
conformation with axial substituents at C4 and C5, with twisting of the C4-C5 bond to minimize 
repulsion between the hexafluoroisopropyl groups, which forces the near-eclipsing of H’s 4 and 
5 (Figure 29). nOe correlations were observed between the 4-O-hexafluoroisopropyl proton and 
the ring protons H4 and H5, while no correlations were seen between H5 and either H3. One of 
the two trifluoromethyl groups in the same 4-O-hexafluoroisopropyl ether also showed 
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heteronuclear nOe correlations with H4 in the HOESY (1H-19F) spectrum further supporting the 
assigned conformation (Figure 30). 
 
Figure 29. H4-H5 Vicinal Coupling of The Disubstitution Product 216. 
 
Figure 30. Key nOe Correlations in Structure 216. 
Table 9. Chemical Shifts and Coupling Constants for 208, 209, 215, and 216.  
 Chemical Shifts (δ, ppm) Coupling Constants (Hz) 







208 2.13 2.50 5.17 4.86 4.23 5.79 10.5 5.5 8.0 9.6 2.1  13.4 
209 2.10 2.53 4.04 4.17 4.33 5.51 4.2  2.5 2.7 10.0 2.6 15.5 
215 2.26 2.37 2.47 2.51 4.16 5.69 5.3 1.8 7.1  3.4 3.9 15.3 





N-Hydroxybenzotriazole (HOBt) with a pKa  4.3132 and N-hydroxysuccinimide with a 
pKa  6.0133  both follow the usual mechanism of direct substitution at the 5-position with 
retention of configuration leading to the observed products 205 and 206, respectively. These 
observations were anticipated because of the acidity of these nucleophiles.  
On the other hand, the use of NHPI as nucleophile gave the direct substitution product at 
the 5-position as well as the unanticipated disubstitution product at 4-and 5-postions. While the 
pKa of NHPI is ~ 6.1,134 the diazonium ion 98 ~ diazoalkane 99 interconversion generates the 
two observed products 207 and 208 in almost equal amounts. The direct substitution at C5 leads 
to the anticipated product 207 from the diazonium ion. The formation of the disubstitution 
product 208 results directly from the β-elimination of the acetoxy group at C4 leading to the 
formation of vinyl diazonium ion 186, by a mechanism similar to that observed with phenol as 
nucleophile discussed in chapter 2. This vinyl diazonium ion is then attacked at C4 by the N-
oxyphthalimide anion under thermodynamic control to form 220, followed by an intermolecular 
proton transfer from another molecule of NHPI to form the intermediate 221, which then loses 
the molecular nitrogen to form the oxonium ion 222. The intermediate 222 is finally substituted 
by N-hydroxyphthalimide, which approaches C5 from the backside leading to the observed 




Scheme 53. Possible Mechanism Formation of the Products 207 and 208. 
The formation of diazoalkane 99 predominates over the diazonium ion 98 in the case of 
acetohydroxamic acid, which has a pKa of 9.40.135 Thus, the bicyclic product 209 isolated is the 
result of an attack by the two most nucleophilic sites of acetohydroxamic acid. The first 
substitution occurred at the 4-position of the vinyl diazonium ion 186-2H by the anionic oxygen 
of acetohydroxamic acid under kinetic Michael addition conditions leading to the intermediate 
223. An intramolecular proton transfer then takes place from the β-face of the intermediate 223 
to form the zwitterion 224. The second substitution at the 5-position occurs through the 
displacement of the nitrogen by the oxy-anion of the imidate moiety that resulted from the 
delocalization of the electrons leading to the isolated product 209 with retention of configuration. 
This reaction also produced a single elimination product 161 after possibly a concerted nitrogen 
loss and deprotonation of H6. Overall, the substitution at the 4-position occurred with inversion 
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of the configuration while that at the 5-position followed retention of the configuration (Scheme 
54). 
 
Scheme 54. Plausible Mechanism of Acetohydroxamic Acid Reaction with Vinyl 
Diazonium Ion. 
The use of N-(4-methoxybenzyl)acetohydroxamic acid with a pKa of 9.15,135 on the other 
hand, provided none of the substitution products but the alkene 211, which was isolated for the 
first time. This alkene 211 possibly results from formation of and subsequent decomposition of 
intermediate 225. This provides a vinyl anion 226, which then is protonated to afford the alkene 
211. N-Boc-acetohydroxamic acid carries the bulky Boc group and is expected to follow a 
similar path of that with N-(4-methoxybenzyl)acetohydroxamic acid as nucleophile leading to 




Scheme 55. Possible Mechanism Formation of the Alkene Product 211. 
The product 214 that was formed on use of p-nitrobenzaldoxime as nucleophile, likely 
occurs through conjugate addition to the vinyl diazonium ion, followed by loss of the molecular 
nitrogen and deprotonation of H4. The ketone 212 resulted from the acidic hydrolysis of the 
electron rich enol ether 214. The enone 213 arose from the presence of more acid in the reaction 
medium (Scheme 56). The use of the more electron rich acetone oxime (pKa 12.4)122 as 
nucleophile, led to the decomposition of the substitution adduct 228. Thus, it provided the ketone 




Scheme 56. Mechanism Formation of Product 214 and the Decomposition of 228. 
The bicyclic aziridine product 215 is formed by the nucleophilic attack of aniline on the 
β-face of the vinyl diazonium ion in a kinetic Michael addition. This mechanism is similar to that 
postulated β-naphthol in chapter 2. Here, the diazonium intermediate 228 can tautomerize to 220, 
followed by cyclization to form a triazoline 230. Subsequently, the triazoline 230 decomposes 
with the loss molecular nitrogen to afford the aziridine 215. Alternatively, comparing with the 
previous work on the reactions of arenes diazonium ions with amines,145,146 aniline attacks the 
terminal nitrogen of the diazonium intermediate 186 to provide a vinyl triazene 229, followed by 
cyclization and loss of nitrogen to give the observed aziridine 215 (Scheme 57). The triazoline 
intermediate 230 was detected by ESI mass spectrometry during the analysis of the crude 
reaction mixture from this reaction: an adduct of m/z 530 (M+Na) for 230 was recorded as a 
major ion peak, which disappeared over time to provide the aziridine 215 (m/z 501, M+Na) 
(Figure 31). The decomposition of triazolines by the loss of nitrogen to form the corresponding 




Scheme 57. Mechanism Formation of Bicyclic Product 215. 
 
Figure 31. Mass Spectrum Showing Unstable Intermediate 230 (~ 530.1836 m/z). 
The deamination using 3,5-dimethylpyrazole as nucleophile, provided a novel 
disubstitution product 216. This product resulted from use of HFIP as a solvent. It was formed by 
kinetic Michael addition on C4 of the vinyl diazonium ion that is similar the described 
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mechanisms in the previous reactions of 2-naphthol and acetohydroxamic acid. Although HFIP 
is a weakly acidic solvent with pKa value of 9.3137 and is poorly nucleophilic,97  substitution with 
inversion of configuration at C5 eventually afforded the product 216. The high electrophilic 
reactivity of the vinyl diazonium and the absence of competitive nucleophiles play an important 
role in the isolation of the product 216 (Scheme 58). 
 
Scheme 58. Formation of Disubstitution Product 216. 
The attempted use of indole as nucleophile provided an inseparable mixture of the 
elimination products in high yield 80%. This reaction most likely reversibly produced an 
unstable triazene 233, that restricts the formation of the vinyl diazonium ion. Eventual loss of 
nitrogen and the β-elimination of H4 and H6 lead to the isolated alkene products 160 and 161 
(Scheme 59).  
 
Scheme 59. Possible Decomposition of 233 and Formation of the Elimination Products. 
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The reaction of indoles with arene diazonium salts has been previously reported to 
provide the related N-arylazoindoles 236, albeit they are sensitive and rapidly decompose 
(Scheme 60).151 
 
Scheme 60. Literature Reaction of Indoles with Arene Diazonium Salts. 
Finally, the use of 2-pyridone and N-hydroxypyridine-2-thione as nucleophiles afforded 
the usual elimination products. These two nucleophiles are in the keto form, which has very poor 
nucleophilic reactivity. It is also possible that they couple with the terminal nitrogen of the 
diazonium ion, similarly to the mechanism proposed for indole (Scheme 59) and retard 
formation of the elimination products 160 and 161.  
3.5 Conclusion  
The use of hydroxylamines, hydroxamic acids, oximes and amines as nucleophiles in the 
oxidative deamination of N-acetyl neuraminic acid were examined. A diverse series of 
neuraminic acid derivatives were formed in these reactions testifying to the compatibility of this 
chemistry. HOBt, N-hydroxysuccinimide and N-hydroxyphthalimide afforded the anticipated 
deamination products with retention of configuration at the 5-position. However, NHPI provided 
an additional disubstitution product with the retention of configuration at C4 arising from 
Michael addition on an intermediate vinyl diazonium, followed the displacement by another 
molecule of NHPI at C5. Acetohydroxamic acid and aniline produced novel bicyclic products 
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with the different configurations and conformations. Oximes as nucleophiles afforded various 
alkenes and ketones as products. Following deprotection of the novel neuraminic acid derivatives 




CHAPTER 4. CONCLUSIONS 
The utilization of the Zbiral oxidative deamination for the transformations of N-acetyl 
neuraminic to various sialic acid derivatives was accomplished in this thesis.  The replacement of 
the N-acetyl moiety with the alternative described nucleophiles showed the feasibility of this 
deamination process. Phenols exhibited effective reactivities as nucleophiles in this deamination 
of the 5-position, although they are only weakly acidic. The use of phenol itself provided a novel 
disubstitution product, along with a product that resulted from β-elimination. β-Naphthol was an 
interesting nucleophile that led to the isolation of an unusual tricyclic product, which was found 
surprisingly to be in a boat conformation. Its structure was confirmed by X-ray crystallography. 
Similar tricyclic products were observed in reactions with 6-quinolinol, 5-hydroxyindole, and the 
electron rich phenols such as 3,5-dimethoxyphenol. On the other hand, the electron poor 
substituted phenols as well as the less acidic phenols such as 3-quinolinol, 4-nitrophenol and 4-
methoxyphenol produced enol ether products. Thiophenols demonstrated the direct substitution 
process at the 5-position because of the presence of stronger sulfur atom as nucleophilic site and 
because of their higher pKa values compared to the simple phenols.  
Further studies involved the use of hydroxylamines, hydroxamic acids, oximes, and 
amines as alternative nucleophiles. These studies further supported the potential significance of 
this deamination as these nucleophiles afforded a series of sialic acid derivatives with a hydroxyl 
amine (N-O) moiety at C5.  
The investigations in this thesis are rationalized by the postulation of a central 
intermediate responsible for the syntheses of these novel and various deamination products, 
namely a vinyl diazonium ion. This intermediate is an example of class of alkenediazonium ions 
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that are under studied as useful intermediates in organic syntheses. An overall mechanism 
rationalizing formation of all products can be advanced (Scheme 61). 
 
Scheme 61. Overall Oxidative Deamination Mechanism.  
84 
 
CHAPTER 5. EXPERIMENTAL SECTION 
General Information:  
All reactions were performed using oven-dried glassware under an atmosphere of argon. 
All reagents and solvents were purchased from commercial suppliers and used without further 
purification unless otherwise specified. Chromatographic purifications were performed on silica 
gel (230−400 mesh) columns (20−50 g) of silica gel per gram of crude compound. Reactions 
were monitored by analytical thin-layer chromatography (TLC) on precoated glassbacked plates 
(w/UV 254) and visualized by UV irradiation (254 nm) or by staining with 25% H2SO4 in EtOH 
or ceric ammonium molybdate solution. Specific rotations were measured on an automatic 
polarimeter with a path length of 100 mm in the solvent specified. Concentrations are given in 
g/100 mL. High-resolution mass spectra (HRMS) were recorded with an electrospray ionization 
(ESI) source coupled to a time-of-flight (TOF) mass analyzer. 1H, 13C, and 19F, spectra were 
recorded on a 400, 500, or 600 MHz spectrometer. NMR solvents were used without purification. 
Chemical shifts are given in ppm (δ), and coupling constants (J) are given in Hertz (Hz). 
Multiplicities are given as singlet (s), broad singlet (br s), doublet (d), triplet (t), doublet of 
doublets (dd), triplet of doublets (td), multiplet (m), apparent quartet (app q), apparent pentet 
(app p), etc. Spectral assignments were made by a combination of correlated spectroscopy, 
heteronuclear single-quantum correlation, and heteronuclear multiple bond correlation spectra. 
General Procedure of Oxidative Deamination. 
 Using the quantities described in the individual experiments, sodium 2,2,2-
trifluoroethoxide and 18-crown-6 were dissolved in anhydrous CH2Cl2 under Ar and cooled to 
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−10 °C. The solution was added to the nitrosyl sialoside (0.1 M solution in anhydrous CH2Cl2) at 
−10 °C under Ar. The mixture was stirred for 5 min at −10 °C. The nucleophile (10−20 equiv) 
dissolved in the solvent described under Ar at −10 °C was added to the reaction mixture in one 
portion. After stirring for 5 min, the reaction was quenched by the addition of saturated NaHCO3 
solution and diluted with dichloromethane. The reaction mixture was washed with NaOH (1 M) 
to remove excess phenolic nucleophile. The organic layer was washed with brine, dried over 
anhydrous Na2SO4, and concentrated under reduced pressure to afford the crude product, which 
was purified by column chromatography over silica gel. 
Methyl (Methyl 5-Acetamido-4,7,8,9-tetra-O-acetyl-3,5-dideoxyD-glycero-β-D-galacto-non-
2-ulopyranosid)onate (158).  
Compound 158 (6 g, 95%) was obtained by a literature procedure74 over two steps as a 
white solid from N-acetyl neuraminic acid (20 g, 64.7 mmol).  
Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-dideoxy-5-(anti/synN-nitrosoacetamido)-D-
glycero-β-D-galacto-non-2-ulopyranosid)onate (74).  
A solution of compound 74 (330 mg, 0.7 mmol) in dry dichloromethane (7 mL) was 
treated with dry pyridine (0.5 mL, 6.5 mmol, 10 equiv) and cooled to −10 °C. After stirring for 
15 min, crushed nitrosyl tetrafluoroborate (382 mg, 3.0 mmol, 5 equiv) was added in one portion. 
The reaction mixture was stirred at −10 °C until TLC showed complete conversion (4−5 h). The 
mixture was diluted with cold dichloromethane (3 mL) and washed with cold 1 N HCl, saturated 
NaHCO3, and brine. The organic layer was dried over anhydrous Na2SO4 and concentrated under 





ulopyranosid)onate (159) and a Mixture of Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-
dideoxy-β-D-arabinonon-4-en-2-ulopyranosid)onate (160) and Methyl (Methyl 
4,7,8,9Tetra-O-acetyl-3,5-dideoxy-β-D-ribo-non-5-en-2-ulopyranosid)onate (161). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and levulinic acid (1.16 g, 10 
mmol, 20 equiv) in CH2Cl2 (5 mL) to afford 159 after column chromatography over silica gel 
eluting with (hexane/ethyl acetate 3:1), as colorless crystals from methanol/CH2Cl2 (88 mg, 
31%) and an inseparable mixture of 160 and 161 as a colorless oil (1:2.5 ratio, 75 mg, 34%). 
Compound 159: colorless crystals, mp = 132−134 °C; [α]D20 − 5.7° (c 0.4, CH2Cl2). 
1H 
NMR (400 MHz, CDCl3) δ 5.34−5.19 (m, 3H, H8, H7, H4), 4.87 (t, J = 9.9 Hz, 1H, H5), 4.65 
(dd, J = 12.6, 2.4 Hz, 1H, H9), 4.09 (dd, J = 12.5, 6.7 Hz, 1H, H9′), 4.00 (dd, J = 10.1, 2.2 Hz, 
1H, H6), 3.75 (s, 3H, CH3), 3.21 (s, 3H, CH3), 2.79−2.69 (m, 1H, H3e), 2.61−2.35 (m, 4H, 
CH2CH2), 2.11 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.02 (s, 3H, CH3), 1.98 (s, 3H, CH3), 1.97 (s, 3H, 
CH3), 1.77 (dd, J = 13.0, 11.5 Hz, 1H, H3a). 
13C NMR (101 MHz, CDCl3) δ 205.9, 171.7, 170.6, 
170.2, 170.0, 167.2, 98.9, 70.9, 70.1, 68.7, 67.8, 67.6, 62.1, 52.7, 51.4, 37.9, 37.8, 37.0, 29.7, 
28.0, 21.0, 20.9, 20.8, 20.7. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C24H34NaO15 585.1795; 
found: 585.1792.  
Compound 161: 1H NMR (400 MHz, CDCl3) δ 5.51 (m, 1H, H8), 5.46 (m, 1H, H7), 5.25 
(m, 1H, H4), 5.07 (dq, J = 4.4, 1.1 Hz, 1H, H5), 4.36 (dd, J = 12.1, 3.0 Hz, 1H, H9), 4.30 (dd, J 
= 12.1, 7.1 Hz, 1H, H9′), 3.75 (s, 3H, CH3), 3.36 (s, 3H, CH3), 2.31 (dd, J = 14.1, 3.6 Hz, 1H, 
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H3), 2.16 (dd, J = 14.2, 5.3 Hz, 1H, H3′), 2.11 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.03 (s, 3H, 
CH3), 1.96 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 170.8, 170.1, 170.0, 169.3, 167.7, 
149.8, 99.2, 98.0, 70.4, 70.3, 63.0, 61.9, 52.7, 52.2, 34.6, 21.1, 20.9, 20.9.  
Compound 160 was identified in the mixture by the following diagnostic signals: 1H 
NMR (400 MHz, CDCl3) δ 5.43 (dd, J = 6.1, 2.5 Hz, 1H, H8), 5.33−5.29 (m, 2H, H7, H5), 4.58 
(ddd, J = 12.6, 2.4, 1.3 Hz, 1H, H9), 4.51 (dq, J = 4.7, 2.5 Hz, 1H, H6), 4.19 (ddd, J = 12.5, 5.9, 
1.3 Hz, 1H, H9′), 3.78 (s, 3H, CH3), 3.24 (s, 3H, CH3), 2.68 (ddd, J = 17.0, 3.9, 2.4 Hz, 1H, H3). 
13C NMR (101 MHz, CDCl3) δ 170.7, 170.4, 169.9, 168.5, 168.0, 144.5, 110.0, 98.1, 70.7, 70.1, 
69.2, 62.4, 52.7, 51.5, 34.8, 21.0, 20.9, 20.7. HRMS (ESI-TOF) m/z: [M + Na]+ calcd for 
C19H26NaO12 469.1322; found: 469.1322. 
Methyl (Methyl 7,8,9-Tri-O-acetyl-3-deoxy-4,5-di-O-phenyl-Dglycero-β-D-gulo-non-2-
ulopyranosid)onate (162) and Methyl (Methyl 7,8,9-Tri-O-acetyl-3,5-dideoxy-4-O-phenyl-
β-D-arabinonon-4-en-2-ulopyranosid)onate (163). 
The nitrosyl sialoside 74 (200 mg, 0.4 mmol) in CH2Cl2 (4 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (90 mg, 0.7 
mmol), 18-crown-6 (195 mg, 0.7 mmol) in CH2Cl2 (2 mL), and phenol (188 mg, 2 mmol, 5 
equiv) in CH2Cl2 (1 mL) followed by column chromatography over silica gel eluting with 
(hexane/ethyl acetate 1:1) to afford 162 (71 mg, 33%) and 163 (56 mg, 31%).  
Compound 162: colorless oil, [α]D20 −32.4° (c 0.25, CHCl3). 
1H NMR (600 MHz, CDCl3) 
δ 7.29−7.23 (m, 4H, ArH), 7.09 (dt, J = 7.7, 1.1 Hz, 2H, ArH), 7.04 (t, J = 7.3 Hz, 1H, ArH), 
6.96 (t, J = 7.3 Hz, 1H, ArH), 6.87 (d, J = 8.5 Hz, 2H, ArH), 5.19 (td, J = 5.8, 3.7 Hz, 1H, H8), 
4.99 (t, J = 5.3 Hz, 1H, H7), 4.52 (dt, J = 8.9, 3.7 Hz, 1H), 4.20 (dd, J = 12.3, 3.6 Hz, 1H, H9), 
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4.14 (dd, J = 12.2, 6.3 Hz, 1H, H9′), 3.56 (s, 3H, CH3), 3.48 (s, 3H, CH3), 3.17−3.12 (m, 2H, H6 
and H5), 2.55 (dd, J = 14.9, 8.9 Hz, 1H, H3a), 2.47 (dd, J = 14.9, 3.2 Hz, 1H, H3e), 2.07 (s, 3H, 
CH3), 2.04 (s, 3H, CH3), 2.02 (s, 3H, CH3). 
1H NMR (600 MHz, C6D6) δ 7.28−7.26 (m, 2H, 
ArH), 7.08 (dt, J = 8.6, 7.3 Hz, 4H, ArH), 6.99−6.96 (m, 2H, ArH), 6.84 (tt, J = 7.3, 1.2 Hz, 1H, 
ArH), 6.78 (tt, J = 7.4, 1.2 Hz, 1H, ArH), 5.36 (ddd, J = 6.2, 5.7, 3.6 Hz, 1H, H8), 5.16 (t, J = 5.7 
Hz, 1H, H7), 4.61 (ddd, J = 8.8, 4.6, 3.4 Hz, 1H, H4), 4.20 (dd, J = 12.3, 3.6 Hz, 1H, H9), 4.15 
(dd, J = 12.2, 6.3 Hz, 1H, H9′), 3.26 (s, 3H, CH3), 3.24 (s, 3H, CH3), 3.18 (dd, J = 5.7, 2.1 Hz, 
1H, H6), 3.01 (dd, J = 4.5, 2.0 Hz, 1H, H5), 2.77 (dd, J = 14.8, 8.8 Hz, 1H, H3a), 2.57 (dd, J = 
14.8, 3.4 Hz, 1H, H3e), 1.65 (s, 3H, CH3), 1.63 (s, 3H, CH3), 1.57 (s, 3H, CH3). 
13C NMR (151 
MHz, CDCl3) δ 170.6, 170.1, 169.7, 168.3, 157.4, 154.4, 129.8, 129.7, 123.3, 122.1, 118.8, 
116.0, 101.3, 71.6, 70.6, 70.5, 61.6, 57.4, 54.1, 52.8, 50.4, 37.1, 20.9, 20.8, 20.8. 13C NMR (151 
MHz, C6D6) δ 169.8, 169.6, 169.3, 168.1, 158.1, 155.1, 129.9, 129.9, 128.2, 128.1, 127.9, 123.3, 
122.1, 119.3, 116.6, 101.8, 72.6, 71.2, 71.0, 61.7, 57.6, 54.4, 52.1, 50.2, 37.4, 20.4, 20.2, 20.1. 
ESIHRMS calculated for (C29H34NaO12): ([M + Na]+) m/z: 597.1948; found: 597.1943. 
Compound 163: colorless oil, [α]D20 −32.1° (c 0.26, CHCl3). 1H NMR (600 MHz, 
CDCl3) δ 7.32 (t, J = 7.9 Hz, 2H, ArH), 7.12 (t, J = 7.4 Hz, 1H, ArH), 6.98 (d, J = 7.7 Hz, 2H, 
ArH), 5.44 (dd, J = 6.2, 2.3 Hz, 1H, H8), 5.26 (dd, J = 6.4, 2.7 Hz, 1H, H7), 4.69 (t, J = 1.9 Hz, 
1H, H5), 4.57 (dd, J = 12.5, 2.4 Hz, 1H, H9), 4.48 (p, J = 2.6 Hz, 1H, H6), 4.21 (dd, J = 12.5, 6.1 
Hz, 1H, H9′), 3.83 (s, 3H, CH3), 3.31 (s, 3H, CH3), 2.65 (ddd, J = 17.2, 3.7, 2.2 Hz, 1H, H3), 
2.54 (dd, J = 17.2, 2.6 Hz, 1H, H3′), 2.08 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.03 (s, 3H, CH3). 
13C 
NMR (151 MHz, CDCl3) δ 170.8, 170.0, 169.9, 168.4, 154.6, 151.0, 129.8 (two carbons), 124.4, 
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120.2 (two carbons), 99.4, 98.5, 71.3, 70.2, 69.4, 62.5, 52.8, 51.6, 34.5, 21.0, 20.9 (two carbons). 
ESI-HRMS calcd for (C23H28NaO11): ([M + Na]+) m/z: 503.1529; found: 503.1529.  
Methyl (Methyl 7,8,9-Tri-O-acetyl-3,4-dideoxy-4-C,5-O-(naphthalen-1,2-diyl)-D-glycero-β-
D-talo-non-2-ulopyranosid)onate (164) and Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-
dideoxy-5-(2-hydroxynaphthalen-1-diazenyl)-D-glycero-β-D-galacto-non-
2ulopyranosid)onate (165).  
The nitrosyl sialoside 74 (534 mg, 1 mmol) in CH2Cl2 (10 mL) was deaminated using the 
general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (244 mg, 2 
mmol), 18-crown-6 (582 mg, 2 mmol) in CH2Cl2 (5 mL), and 2-naphthol (2.88 g, 20 mmol, 20 
equiv) in Et2O (10 mL) to afford, after flash chromatography over silica gel eluting with 
(hexane/ethyl acetate 1:1), 164 as white crystals (282 mg, 57%) from diethyl ether and 165 as 
deep yellow crystals (81 mg, 13%) from methanol/CH2Cl2.  
Compound 164: white crystals, mp = 107−109 °C; [α]D20 −116.0° (c 1.0, CHCl3). 
1H 
NMR (400 MHz, CDCl3) δ 7.81 (d, J = 8.2 Hz, 1H, ArH), 7.69 (d, J = 8.8 Hz, 1H, ArH), 7.53 
(dd, J = 8.0, 1.2 Hz, 1H, ArH), 7.46 (ddd, J = 8.3, 6.7, 1.2 Hz, 1H, ArH), 7.32 (ddd, J = 8.1, 6.7, 
1.3 Hz, 1H, ArH), 7.10 (d, J = 8.8 Hz, 1H, ArH), 5.69 (dd, J = 6.0, 5.1 Hz, 1H, H7), 5.47 (td, J = 
6.0, 2.7 Hz, 1H, H8), 4.94 (t, J = 9.2 Hz, 1H, H5), 4.48 (dd, J = 12.3, 2.7 Hz, 1H, H9), 4.35 (dd, 
J = 12.3, 6.0 Hz, 1H, H9′), 4.21 (dd, J = 9.4, 5.1 Hz, 1H, H6), 3.92 (s, 3H, CH3), 3.87 (ddd, J = 
13.5, 9.2, 5.0 Hz, 1H, H4), 3.31 (s, 3H, CH3), 2.86 (dd, J = 14.9, 5.0 Hz, 1H, H3pe), 2.18 (s, 3H, 
CH3), 2.10 (s, 3H, CH3), 2.09 (s, 3H, CH3), 1.90 (dd, J = 14.9, 13.5 Hz, 1H, H3pa). 
13C NMR 
(101 MHz, CDCl3) δ 170.8, 170.2, 169.9, 169.3, 157.1, 130.4, 130.0, 129.8, 129.1, 127.2, 123.4, 
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122.1, 119.8, 112.5, 99.4, 80.0, 70.6, 69.8, 69.6, 61.8, 53.0, 51.7, 37.1, 34.1, 21.0, 20.9. ESI-
HRMS calcd for (C27H30O11Na): ([M + Na]+) m/z: 553.1686; found: 553.1686.  
Compound 165: deep yellow crystals; mp = 163−165 °C; [α]D 20 −21.6° (c 0.7, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 8.47 (d, J = 8.3 Hz, 1H, ArH), 7.75 (d, J = 9.2 Hz, 1H, ArH), 
7.65 (d, J = 7.9 Hz, 1H, ArH), 7.53 (ddd, J = 8.3, 7.0, 1.4 Hz, 1H, ArH), 7.38 (ddd, J = 8.1, 7.1, 
1.3 Hz, 1H, ArH), 6.98 (d, J = 9.3 Hz, 1H, ArH), 5.86 (ddd, J = 11.2, 10.0, 5.1 Hz, 1H, H4), 5.42 
(td, J = 6.1, 2.4 Hz, 1H, H8), 5.35 (dd, J = 6.5, 1.9 Hz, 1H, H7), 4.60 (dd, J = 12.5, 2.5 Hz, 1H, 
H9), 4.44 (dd, J = 10.4, 1.9 Hz, 1H, H6), 4.18−4.07 (m, 1H, H9), 4.00 (t, J = 10.2 Hz, 1H, H5), 
3.83 (s, 3H, CH3), 3.32 (s, 3H, CH3), 2.66 (dd, J = 12.9, 5.1 Hz, 1H, H3), 2.13 (s, 3H, CH3), 2.02 
(s, 3H, CH3), 1.94 (s, 3H, CH3), 1.83 (s, 3H, CH3), 1.26−1.22 (m, 1H, H3′). 
13C NMR (101 MHz, 
CDCl3) δ 170.7, 170.1, 169.7, 169.5, 167.4, 161.9, 138.1, 133.3, 129.7, 128.5, 128.4, 128.0, 
125.1, 122.5, 121.3, 99.0, 70.4, 70.2, 69.5, 68.9, 67.5, 62.1, 52.8, 51.5, 36.7, 21.0, 20.8, 20.7, 
20.7. UV/vis λmax = 380 nm (acetonitrile, ε = 8699 M−1 cm−1). ESIHRMS calcd for (C29H34 
N2O13Na): ([M + Na]+) m/z: 641.1959; found: 641.1964.  
Methyl (Methyl 7,8,9-Tri-O-acetyl-3,5-dideoxy-4-O-(4-methoxyphenyl)-β-D-arabino-non-4-
en-2-ulopyranosid)onate (166).  
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and 4-methoxyphenol (1.24 g, 10 
mmol, 20 equiv) in CH2Cl2 (5 mL) to afford, after flash column chromatography over silica gel 
eluting with (toluene/ethyl acetate 3:1), 166 as a colorless oil (92 mg, 36%); [α]D20 −10.9° (c 0.7, 
CH2Cl2). 
1H NMR (600 MHz, CDCl3) δ 6.93−6.87 (m, 2H, ArH), 6.87−6.80 (m, 2H, ArH), 5.42 
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(td, J = 6.2, 2.3 Hz, 1H, H8), 5.23 (dd, J = 6.3, 2.7 Hz, 1H, H7), 4.56 (dd, J = 12.5, 2.4 Hz, 1H, 
H9), 4.51 (t, J = 1.9 Hz, 1H, H5), 4.45 (dt, J = 5.3, 2.6 Hz, 1H, H6), 4.19 (dd, J = 12.5, 6.1 Hz, 
1H, H9′), 3.83 (s, 3H, CH3), 3.78 (s, 3H, CH3), 3.30 (s, 3H, CH3), 2.64 (ddd, J = 17.1, 3.5, 2.0 
Hz, 1H, H3), 2.53 (dd, J = 17.1, 2.5 Hz, 1H, H3′), 2.07 (s, 3H, CH3), 2.03 (s, 3H, CH3), 2.02 (s, 
3H, CH3). 
13C NMR (151 MHz, CDCl3) δ 170.8, 170.0, 169.8, 168.5, 156.6, 152.0, 147.6, 121.8, 
114.8, 98.4, 96.9, 71.4, 70.2, 69.4, 62.5, 55.7, 52.8, 51.6, 34.6, 21.0, 20.9 (two carbons). HRMS 
(ESITOF) m/z: [M + Na]+ calcd for C24H30NaO12 533.1635; found: 533.1636.  
Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3-deoxy-5-O-(4-nitrophenyl)-D-glycero-β-D-galacto-
non-2-ulopyranosid)onate (167) and Methyl (Methyl 7,8,9-Tri-O-acetyl-3,5-dideoxy-4-O-(4-
nitrophenyl)-β-D-arabino-non-4-en-2-ulopyranosid)onate (168). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and 4-nitrophenol (1.39 g, 10 
mmol, 20 equiv) in tetrahydrofuran (THF) (5 mL) to afford 167 (27 mg, 9%), and 168 (25 mg, 
9%), and an inseparable mixture of 160 and 161 (52 mg, 23%) after flash column 
chromatography over silica gel eluting with (toluene/ethyl acetate 3:1).  
Compound 167: colorless oil, [α]D20 −3.7° (c 0.8, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 
8.17 (d, J = 9.3 Hz, 2H, ArH), 6.97 (d, J = 9.2 Hz, 2H, ArH), 5.42 (dd, J = 4.8, 2.2 Hz, 1H, H7), 
5.30 (ddd, J = 7.2, 4.9, 2.5 Hz, 1H, H8), 5.14 (dd, J = 10.1, 9.3 Hz, 1H, H5), 4.88 (ddd, J = 11.3, 
9.2, 4.9 Hz, 1H, H4), 4.77 (dd, J = 12.5, 2.5 Hz, 1H, H9), 4.14 (dd, J = 12.5, 7.1 Hz, 1H, H9′), 
4.11 (dd, J = 10.1, 2.2 Hz, 1H, H6), 3.82 (s, 3H, CH3), 3.31 (s, 3H, CH3), 2.66 (dd, J = 13.3, 4.9 
Hz, 1H, H3e), 2.14 (s, 3H, CH3), 2.08 (s, 3H, CH3), 2.03 (s, 3H, CH3), 1.95 (dd, J = 13.3, 11.3 
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Hz, 1H, H3a), 1.87 (s, 3H, CH3). 
13C NMR (151 MHz, CDCl3) δ 170.6, 170.5, 170.2, 169.6, 
167.1, 162.6, 142.2, 126.1, 115.6, 99.1, 74.3, 71.3, 70.6, 68.4, 67.6, 62.3, 53.1, 51.6, 37.3, 21.1, 
20.9, 20.8 (two carbons). HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C25H31NNaO15 608.1591; 
found: 608.1595.  
Compound 168: colorless oil, [α]D 20 −46.8° (c 0.6, CHCl3). 
1H NMR (600 MHz, CDCl3) 
δ 8.20 (d, J = 9.2 Hz, 2H, ArH), 6.90 (d, J = 9.2 Hz, 2H, ArH), 5.56−5.51 (m, 2H, H8 and H7), 
5.18 (d, J = 3.6 Hz, 1H, H5), 5.04 (tdd, J = 5.5, 3.8, 1.2 Hz, 1H, H4), 4.41 (dd, J = 12.2, 2.7 Hz, 
1H, H9), 4.33 (dd, J = 12.1, 7.1 Hz, 1H, H9′), 3.79 (s, 3H, CH3), 3.41 (s, 3H, CH3), 2.43 (dd, J = 
13.8, 5.6 Hz, 1H, H3), 2.37 (dd, J = 13.8, 5.3 Hz, 1H, H3′), 2.14 (s, 3H, CH3), 2.07 (s, 3H, CH3), 
2.065 (s, 3H, CH3). 
13C NMR (151 MHz, CDCl3) δ 170.8, 170.1, 169.4, 167.4, 162.0, 149.9, 
142.0, 126.2, 126.1, 118.2, 115.6, 115.5, 99.4, 97.9, 70.5, 70.4, 66.9, 61.9, 53.0, 52.4, 34.5, 21.0, 




The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and 3,5-dimethoxyphenol (1.54 g, 
10 mmol, 20 equiv) in CH2Cl2 (5 mL) to afford 169, after flash column chromatography over 
silica gel eluting with (hexane/ethyl acetate 1:1), as a colorless oil in (92 mg, 34%); [α]D20 −79.8° 
(c 0.93, CH2Cl2). 
1H NMR (600 MHz, CDCl3) δ 6.02 (d, J = 2.0 Hz, 1H, ArH), 5.97 (d, J = 2.0 
Hz, 1H, ArH), 5.59 (dd, J = 6.4, 4.6 Hz, 1H, H7), 5.39 (td, J = 6.1, 2.6 Hz, 1H, H8), 4.70 (t, J = 
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9.4 Hz, 1H, H5), 4.41 (dd, J = 12.3, 2.7 Hz, 1H, H9), 4.28 (dd, J = 12.4, 5.8 Hz, 1H, H9′), 4.03 
(dd, J = 9.4, 4.6 Hz, 1H, H6), 3.82 (s, 3H, CH3), 3.73 (s, 3H, CH3), 3.72 (s, 3H, CH3), 3.47 (ddd, 
J = 12.9, 9.1, 5.4 Hz, 1H, H4), 3.25 (s, 3H, CH3), 2.63 (dd, J = 14.9, 5.4 Hz, 1H, H3pe), 2.14 (s, 
3H, CH3), 2.06 (s, 6H, CH3), 1.79 (dd, J = 14.9, 12.9 Hz, 1H, H3pa). 
13C NMR (151 MHz, 
CDCl3) δ 170.7, 170.1, 169.7, 169.4, 162.1, 161.1, 157.1, 107.5, 99.4, 91.8, 88.7, 79.5, 70.2, 
69.7, 69.2, 61.7, 55.6, 55.3, 52.8, 51.5, 35.2, 33.7, 21.0, 20.8. ESIHRMS calcd for 
(C25H32NaO13): ([M + Na]+) m/z: 563.1741; found: 563.1715.  
Deamination of Nitrosyl Sialoside 74 with 2-Quinolinol as Nucleophile.  
The nitrosyl sialoside 74 (306 mg, 0.6 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (140 mg, 
1.1 mmol), 18-crown-6 (300 mg, 1.1 mmol) in CH2Cl2 (3 mL), and 2-quinolinol (165 mg, 1.1 
mmol) in Et2O (10 mL) to afford, after flash column chromatographic separation over silica gel 
(hexane/ethyl acetate 1:1), a mixture of compounds 160 and 161 (1:2.5 ratio; 220 mg, 86%).  
Methyl (Methyl 7,8,9-Tri-O-acetyl-3,5-dideoxy-4-O-(quinolin-3yl)-β-D-arabino-non-4-en-2-
ulopyranosid)onate (170) and Methyl (Methyl 7,8,9-Tri-O-acetyl-3,5-dideoxy-4-O-
(quinolin-3-yl)-β-D-ribonon-5-en-2-ulopyranosid)onate (171). 
The nitrosyl sialoside 74 (330 mg, 0.6 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (146 mg, 
1.2 mmol), 18-crown-6 (317 mg, 1.2 mmol) in CH2Cl2 (3 mL), and 3-quinolinol (1.2 g, 8.5 
mmol) in Et2O (10 mL) to afford, after flash column chromatography over silica gel eluting with 




Compound 170: [α]D20 −42.1° (c 0.28, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 8.69 (d, J 
= 2.8 Hz, 1H, ArH), 8.11 (d, J = 8.5 Hz, 1H, ArH), 7.77 (d, J = 8.2 Hz, 1H, ArH), 7.73 (d, J = 
2.7 Hz, 1H, ArH), 7.67 (ddd, J = 8.4, 6.7, 1.5 Hz, 1H, ArH), 7.56 (t, J = 7.5 Hz, 1H, ArH), 5.46 
(td, J = 6.3, 2.5 Hz, 1H, H8), 5.29 (dd, J = 6.5, 2.8 Hz, 1H, H7), 4.89 (t, J = 2.0 Hz, 1H, H5), 
4.56 (dd, J = 12.5, 2.4 Hz, 1H, H9), 4.52 (q, J = 2.7 Hz, 1H, H6), 4.21 (dd, J = 12.5, 6.0 Hz, 1H, 
H9′), 3.84 (s, 3H, CH3), 3.34 (s, 3H, CH3), 2.73 (ddd, J = 17.0, 3.7, 2.1 Hz, 1H, H3), 2.61 (dd, J 
= 17.1, 2.4 Hz, 1H, H3′), 2.12 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.03 (s, 3H, CH3). 
13C NMR (101 
MHz, CDCl3) δ 170.8, 170.0, 169.8, 168.1, 150.6, 148.1, 145.6, 129.4, 128.5, 127.5, 127.3, 
122.9, 101.3, 98.4, 71.1, 70.0, 69.3, 62.4, 52.8, 51.7, 34.3, 21.0, 20.9, 20.8. HRMS (ESI-TOF) 
m/z: [M + Na]+ calcd for C26H29NO11Na 554.1638; found: 554.1636. 
 Compound 171: [α]D 20 −26.2° (c 0.2, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 8.57 (d, J 
= 2.8 Hz, 1H, ArH), 8.03 (d, J = 8.3 Hz, 1H, ArH), 7.72 (d, J = 8.1 Hz, 1H, ArH), 7.57 (t, J = 7.6 
Hz, 1H, ArH), 7.51 (t, J = 7.5 Hz, 1H, ArH), 7.40 (d, J = 2.9 Hz, 1H, ArH), 5.58− 5.53 (m, 2H, 
H8, H7), 5.24 (d, J = 3.8 Hz, 1H, H5), 5.06 (tdd, J = 5.3, 3.7, 1.3 Hz, 1H, H4), 4.43 (dd, J = 12.2, 
2.8 Hz, 1H, H9), 4.36 (dd, J = 12.1, 7.2 Hz, 1H, H9′), 3.80 (s, 3H, CH3), 3.42 (s, 3H, CH3), 2.51 
(dd, J = 13.8, 5.4 Hz, 1H, H3), 2.40 (dd, J = 13.8, 5.3 Hz, 1H, H3′), 2.13 (s, 3H, CH3), 2.06 (s, 
6H, 2 × CH3). 
13C NMR (101 MHz, CDCl3) δ 170.8, 170.1, 169.4, 167.5, 150.2, 149.6, 128.7, 
127.5, 126.9, 99.4, 98.3, 70.5, 70.4, 66.8, 61.9, 53.0, 52.4, 34.4, 21.0, 20.9 (two carbons). HRMS 
(ESI-TOF) m/z: [M + Na]+ calcd for C26 H29NO11Na 554.1638; found: 554.1636.  
Methyl (Methyl 7,8,9-Tri-O-acetyl-3,4-dideoxy-4-C,5-O-(quinoline-5,6-diyl)-D-glycero-β-D-
talo-non-2-ulopyranosid)onate (172).  
95 
 
The nitrosyl sialoside 74 (200 mg, 0.4 mmol) in CH2Cl2 (4 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (91 mg, 0.7 
mmol), 18-crown-6 (195 mg, 0.7 mmol) in CH2Cl2 (3 mL), and 6-quinolinol (1.1 g, 7.6 mmol) in 
hexafluoroisopropanol (3 mL) to afford, after flash column chromatography over silica gel 
eluting with (hexane/ethyl acetate 1:2), 172 as a light yellow oil (105 mg, 53%) and an 
inseparable mixture of 160 and 161 as a colorless oil (25 mg, 11%).  
Compound 172: [α]D 20 −85.1° (c 0.37, CH2Cl2). 
1H NMR (600 MHz, CDCl3) δ 8.78 (dd, 
J = 4.2 Hz, 1H, ArH), 8.01 (d, J = 9.0 Hz, 1H, ArH), 7.91 (d, J = 8.3 Hz, 1H, ArH), 7.39 (dd, J = 
8.4, 4.2 Hz, 1H, ArH), 7.34 (d, J = 9.0 Hz, 1H, ArH), 5.68 (dd, J = 6.1, 5.0 Hz, 1H, H7), 5.46 (td, 
J = 6.0, 2.6 Hz, 1H, H8), 4.99 (dd, J = 9.3, 8.9 Hz, 1H, H5), 4.48 (dd, J = 12.3, 2.7 Hz, 1H, H9), 
4.34 (dd, J = 12.3, 6.0 Hz, 1H, H9′), 4.21 (dd, J = 9.3, 5.0 Hz, 1H, H6), 3.91 (s, 3H, CH3), 3.88 
(ddd, J = 13.4, 8.9, 5.1 Hz, 1H, H4), 3.31 (s, 3H, CH3), 2.78 (dd, J = 14.9, 5.1 Hz, 1H, H3pe), 
2.18 (s, 3H, CH3), 2.10 (s, 3H), 2.09 (s, 3H), 1.92 (dd, J = 14.9, 13.4 Hz, 1H, H3pa). 
13C NMR 
(151 MHz, CDCl3) δ 170.8, 170.3, 169.9, 169.2, 157.3, 147.3, 133.2, 131.6, 130.4, 125.5, 121.9, 
119.8, 115.9, 99.2, 80.5, 70.5, 69.8, 69.5, 61.7, 53.1, 51.8, 36.9, 34.3, 21.2, 21.1, 21.0. HRMS 
(ESI-TOF) m/z: [M + Na]+ calcd for C26H29NO11Na 554.1638; found: 554.1634. 
 Methyl (Methyl 7,8,9-Tri-O-acetyl-3,4-dideoxy-4-C,5-O-(indol-4,5-diyl)-D-glycero-β-D-
talo-non-2-ulopyranosid)onate (173) and Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-
dideoxy-5-(5-hydroxyindol-4-diazenyl)-D-glycero-β-D-galacto-non-2-ulopyranosid)onate 
(174) 
 The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
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mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and 5-hydroxyindole (1.33 g, 10 
mmol, 20 equiv) in THF (5 mL) to afford, after flash column chromatography over silica gel 
eluting with (hexane/ethyl acetate 1:1), 173 as a colorless oil (72 mg, 27%), 174 (28 mg, 9%) as 
deep yellow crystals from methanol/CH2Cl2, and an inseparable mixture of 160 and 161 (16 mg, 
7%). 
Compound 173: colorless oil, [α]D 20 −104.8° (c 0.4, CH2Cl2). 
1H NMR (600 MHz, 
CDCl3) δ 8.13 (s, 1H, NH), 7.22 (t, J = 2.9 Hz, 1H, ArH), 7.17 (d, J = 8.6 Hz, 1H, ArH), 6.74 (d, 
J = 8.6 Hz, 1H, ArH), 6.32 (ddd, J = 3.1, 2.0, 1.0 Hz, 1H, ArH), 5.67 (dd, J = 6.1, 5.0 Hz, 1H, 
H7), 5.47 (td, J = 6.1, 2.8 Hz, 1H, H8), 4.82 (dd, J = 9.4, 8.8 Hz, 1H, H5), 4.46 (dd, J = 12.3, 2.8 
Hz, 1H, H9), 4.32 (dd, J = 12.3, 6.1 Hz, 1H, H9′), 4.12 (dd, J = 9.4, 5.0 Hz, 1H, H6), 3.88 (s, 
3H), 3.77 (ddd, J = 12.8, 8.8, 5.5 Hz, 1H, H4), 3.28 (s, 3H, CH3), 2.72 (dd, J =14.9, 5.5 Hz, 1H, 
H3pe), 2.17 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.07 (s, 3H, CH3), 2.02 (dd, J =14.9, 12.8 Hz, 1H, 
H3pa). 13C NMR (151 MHz, CDCl3) δ 170.9, 170.3, 169.9, 169.6, 153.3, 132.3, 126.0, 124.5, 
116.9, 110.9, 106.0, 99.5, 99.4, 78.7, 70.7, 69.9, 69.6, 61.9, 53.0, 51.6, 37.6, 34.2, 21.1, 21.0. 
HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C25H29NNaO11 542.1638; found: 542.1637.  
Compound 174: mp = 209 − 210 °C; [α]D 20 −51.1° (c 0.45, CHCl3). 
1H NMR (600 MHz, 
CDCl3) δ 11.44 (s, 1H), 8.31 (s, 1H, ArH), 7.36 (d, J = 8.7, 0.9 Hz, 1H, ArH), 6.94 (ddd, J = 2.9, 
2.0, 0.8 Hz, 1H, ArH), 6.82 (d, J = 8.8 Hz, 1H, ArH), 6.00 (ddd, J = 11.4, 9.9, 5.1 Hz, 1H, H4), 
5.42 (td, J = 6.1, 2.6 Hz, 1H, H8), 5.34 (dd, J = 6.3, 1.9 Hz, 1H, H7), 4.61 (dd, J = 12.5, 2.5 Hz, 
1H, H9), 4.44 (dd, J = 10.4, 1.9 Hz, 1H, H6), 4.14 (dd, J = 12.5, 6.0 Hz, 1H, H9′), 4.02 (t, J = 
10.1 Hz, 1H, H5), 3.84 (s, 3H, CH3), 3.32 (s, 3H, CH3), 2.65 (dd, J = 12.9, 5.1 Hz, 1H, H3e), 
2.17 (s, 3H, CH3), 2.02 (s, 3H, CH3), 1.97 (s, 3H, CH3), 1.87 (dd, J = 12.8, 11.6 Hz, 1H, H3a), 
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1.85 (s, 3H, CH3). 
13C NMR (151 MHz, CDCl3) δ 170.9, 170.2, 169.9, 169.5, 167.7, 149.3, 
130.6, 128.9, 126.6, 118.1, 113.2, 101.4, 99.1, 74.2, 70.4, 70.2, 69.1, 67.5, 62.2, 52.9, 51.5, 36.5, 
21.1, 20.9 (three carbons). UV/ vis λmax = 365 nm (dichloromethane, ε = 2391 M−1 cm−1). 
HRMS (ESI-TOF) m/z: [M + Na]+ calcd for C27H33N3NaO13 630.1911; found: 630.1904.  
Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-dideoxy-5-phenylthio-D-glycero-β-D-galacto-
non-2-ulopyranosid)onate (175) and Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-dideoxy-β-
D-gluco-non-2ulopyranosid)onate (176). 
The nitrosyl sialoside 74 (200 mg, 0.4 mmol) in CH2Cl2 (4 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (90 mg, 0.7 
mmol), 18-crown-6 (97 mg, 0.4 mmol) in CH2Cl2 (2 mL), and thiophenol (0.8 mL, 7.4 mmol) to 
afford 175 (48 mg, 23%) and 176 (32 mg, 19%) after flash column chromatography over silica 
gel eluting with (hexane/ethyl acetate 1:1). 
 Compound 175: yellow oil, [α]D 20 −59.4° (c 0.5, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 
7.45−7.40 (m, 3H, ArH), 7.36−7.32 (m, 2H, ArH), 5.98 (dd, J = 4.7, 1.8 Hz, 1H, H7), 5.29 (td, J 
= 10.9, 5.0 Hz, 1H, H4), 5.23 (ddd, J = 7.2, 4.7, 2.6 Hz, 1H, H8), 4.71 (dd, J = 12.4, 2.5 Hz, 1H, 
H9), 4.12 (dd, J = 12.4, 7.1 Hz, 1H, H9′), 3.87 (dd, J = 11.1, 1.9 Hz, 1H, H6), 3.78 (s, 3H), 3.17 
(s, 3H), 2.88 (t, J = 10.9 Hz, 1H, H5), 2.53 (dd, J = 12.8, 4.9 Hz, 1H, H3e), 2.08 (s, 3H), 2.04 (s, 
3H), 2.00 (s, 3H), 1.92 (s, 3H), 1.73 (dd, J = 12.8, 11.1 Hz, 1H, H3a). 13C NMR (151 MHz, 
CDCl3) δ 170.6, 170.4, 169.6, 169.5, 167.4, 134.8, 133.8, 132.09, 132.03, 131.3, 122.3, 98.5, 
71.7, 71.3, 69.7, 69.0, 62.2, 52.6, 51.3, 48.7, 37.9, 29.6, 20.96, 20.91, 20.7, 20.3. ESI-HRMS 
calcd for (C25H32NaO12S): ([M + Na]
+) m/z: 579.1512; found: 579.1519. 
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  Compound 176: colorless oil, [α]D20 −21.9° (c 2.1, CHCl3). 
1H NMR (600 MHz, CDCl3) 
δ 5.33 (td, J = 6.0, 2.6 Hz, 1H, H8), 5.26 (dd, J = 6.2, 3.2 Hz, 1H, H7), 5.20 (m 1H, H4), 4.56 
(dd, J = 12.8, 2.6 Hz, 1H, H9), 4.22 (dd, J = 12.6, 5.9 Hz, 1H, H9), 3.99 (dd, J = 11.9, 3.2 Hz, 
1H, H6), 3.78 (s, 3H, CH3), 3.19 (s, 3H, CH3), 2.35 (dd, J = 12.8, 4.9 Hz, 1H, H3e), 2.14 (s, 3H, 
CH3), 2.07 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.02 (s, 3H, CH3), 1.64−1.56 (m, 2H, H5e, H3a), 
1.38 (q, J = 12.0 Hz, 1H, H5a). 13C NMR (151 MHz, CDCl3) δ 170.7, 170.2, 170.1, 170.1, 168.1, 
99.4, 71.7, 70.3, 68.2, 66.5, 62.0, 52.7, 50.9, 37.3, 32.2, 21.2, 21.0, 20.8 (two carbons). HRMS 
(ESI-TOF) m/z: [M + Na]+ calcd for C19H28NaO12 471.1478; found: 471.1479. 
 Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-dideoxy-5-(2-aminophenyl-thio)-D-glycero-β-D-
galacto/gulo-non-2-ulopyranosid)onate (177) and Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-
3,5-dideoxy-β-D-gluco-non-2-ulopyranosid)onate (176)  
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and 2-aminothiophenol (1.25 g, 10 
mmol, 20 equiv) in CH2Cl2 (5 mL) to afford, after flash column chromatography over silica gel 
eluting with (hexane/ethyl acetate 2:1), 177 (167 mg, 58%) as a mixture of two isomers (ratio; 
axial/equatorial = 1:3) and 176 (64 mg, 28%). 
Major isomer (D-glycero-D-galacto): colorless oil, 1H NMR (600 MHz, CDCl3) δ 7.33 
(dd, J = 7.7, 1.5 Hz, 1H, ArH), 7.09 (ddd, J = 8.0, 7.3, 1.5 Hz, 1H, ArH), 6.67 (dd, J = 8.1, 1.3 
Hz, 1H, ArH), 6.65 (td, J = 7.6, 1.2 Hz, 1H, ArH), 5.97 (dd, J = 5.1, 1.5 Hz, 1H, H7), 5.27 (ddd, 
J = 6.8, 5.1, 2.5 Hz, 1H, H8), 5.22 (td, J = 10.6, 5.0 Hz, 1H, H4), 4.67 (dd, J = 12.5, 2.5 Hz, 1H, 
H9), 4.14 (dd, J = 12.5, 6.9 Hz, 1H, H9′), 3.96 (dd, J = 11.1, 1.6 Hz, 1H, H6), 3.75 (s, 3H, CH3), 
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3.15 (s, 3H, CH3), 2.94 (t, J = 10.7 Hz, 1H, H5), 2.51 (dd, J = 12.8, 5.1 Hz, 1H, H3e), 2.07 (s, 
3H, CH3), 2.03 (s, 3H, CH3), 2.02 (s, 3H, CH3), 1.89 (s, 3H, CH3), 1.63 (dd, J = 12.8, 10.9 Hz, 
1H, H3a). 13C NMR (151 MHz, CDCl3) δ 170.7, 170.5, 170.0, 169.8, 167.5, 136.7, 130.6, 118.7, 
115.4, 113.7, 98.5, 71.7, 71.7, 70.1, 70.0, 62.4, 52.6, 51.3, 47.0, 37.6, 21.1, 20.9, 20.6.  
Minor isomer (D-glycero-D-gulo): 1H NMR (600 MHz, CDCl3) δ 7.44 (dd, J = 8.3, 1.4 
Hz, 1H, ArH), 7.04 (td, J = 7.7, 1.5 Hz, 1H, ArH), 5.86 (dd, J = 7.6, 4.1 Hz, 1H, H7), 5.41 (dt, J 
= 6.0, 4.6 Hz, 1H), 4.37 (dd, J = 12.0, 4.8 Hz, 1H, H9), 4.18 (dd, J = 12.0, 5.9 Hz, 1H, H9′), 4.09 
(dd, J = 7.6, 1.7 Hz, 1H, H6), 3.80 (s, 3H, CH3), 3.21 (s, 3H, CH3), 2.66 (dd, J = 12.9, 12.0 Hz, 
1H, H3), 2.10 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.05 (s, 3H, CH3), 1.46 (s, 3H, CH3). 
13C NMR 
(151 MHz, CDCl3) δ 170.3, 170.0, 167.5, 148.8, 137.0, 129.8, 118.8, 116.5, 115.5, 98.9, 71.2, 
70.3, 69.5, 61.4, 52.8, 51.0, 48.0, 32.7, 21.0, 20.9, 20.8, 20.2.  
Compounds 177: ESI-HRMS calcd for (C25H33NNaO12S): ([M + Na]
+) m/z: 594.1621; 
found: 594.1621.  
Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-3,5-dideoxy-5-(naphthalen-2-thio)-D-glycero-β-D-
galacto/gulo-non-2-ulopyranosid)onate (178) and Methyl (Methyl 4,7,8,9-Tetra-O-acetyl-
3,5-dideoxy-Dgluco-non-2-ulopyranosid)onate (176). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL), and 2-naphthalenethiol (1.60 g, 10 
mmol, 20 equiv) in CH2Cl2 (5 mL) to afford, after flash column chromatography over silica gel 
eluting with (hexane/ethyl acetate 3:1), 178 as a colorless oil (92 mg, 30%), a mixture of 178 and 
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its stereoisomer 178a as a colorless oil (76 mg, 25%) in the axial/ equatorial ratio 1:4 by 1H 
NMR, and 176 (30 mg, 13%).  
Compound 178 (D-glycero-D-galacto): colorless oil (92 mg, 30%), [α]D20 −34.7° (c 2.5, 
CH2Cl2). 
1H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 1.8 Hz, 1H, ArH), 7.79 (dd, J = 7.8, 1.6 Hz, 
2H, ArH), 7.77 (d, J = 8.5 Hz, 1H, ArH), 7.52 (dd, J = 8.6, 1.9 Hz, 1H, ArH), 7.48 (m, 2H, ArH), 
6.08 (dd, J = 4.8, 1.9 Hz, 1H, H7), 5.38 (td, J = 10.9, 5.0 Hz, 1H, H4), 5.25 (ddd, J = 7.2, 4.8, 2.6 
Hz, 1H, H8), 4.69 (dd, J = 12.4, 2.6 Hz, 1H, H9), 4.12 (dd, J = 12.4, 7.1 Hz, 1H, H9), 3.94 (dd, J 
= 11.0, 1.9 Hz, 1H, H6), 3.77 (s, 3H, CH3), 3.12 (s, 3H, CH3), 3.03 (t, J = 10.9 Hz, 1H, H5), 2.54 
(dd, J = 12.9, 5.1 Hz, 1H, H3e), 2.03 (s, 3H, CH3), 2.01 (s, 3H, CH3), 1.96 (s, 3H, CH3), 1.80 (s, 
3H, CH3), 1.76 (dd, J = 12.9, 11.1 Hz, 1H, H3a). 
13C NMR (151 MHz, CDCl3) δ 170.7, 170.6, 
169.8, 169.5, 167.6, 133.6, 132.9, 132.7, 130.3, 129.4, 128.7, 127.7, 127.7, 126.8, 126.7, 98.7, 
71.8, 71.7, 70.0, 69.4, 62.5, 52.7, 51.4, 48.8, 38.1, 21.0, 21.0, 20.9, 20.4. HRMS (ESI-TOF) m/z: 
[M + Na]+ calcd for C29H34O12SNa 629.1669; found: 629.1669.  
The minor D-glycero-D-gulo isomer 178a was identified from a mixture with the major 
isomer by the following signals: 1H NMR (400 MHz, CDCl3) δ 8.02 (d, J = 1.8 Hz, 1H, ArH), 
7.81−7.75 (m, 3H, ArH), 7.59 (dd, J = 8.6, 1.9 Hz, 1H, ArH), 7.48−7.43 (m, 2H, ArH), 5.94 (dd, 
J = 4.8, 1.9 Hz, 1H, H7), 5.52 (ddd, J = 7.2, 4.8, 2.6 Hz, 1H, H8), 5.38 (m, 1H, H4), 4.46 (dd, J = 
12.4, 2.6 Hz, 1H, H9), 4.18−4.10 (m, 2H, H6, H9), 3.95 (m, 1H, H5), 3.82 (s, 3H, CH3), 3.24 (s, 
3H, CH3), 2.60 (dd, J = 12.9, 11.1 Hz, 1H, H3), 2.16 (dd, J = 12.9, 5.1 Hz, 1H, H3), 2.12 (s, 3H, 
CH3), 2.09 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 170.8, 170.4, 170.2, 169.7, 167.4, 
133.7, 132.7, 132.0, 131.1, 129.4, 129.3, 128.2, 127.3, 126.6, 126.2, 98.9, 71.8, 70.7, 69.7, 68.9, 





Dry ethylene glycol (20 μL) and a few crystals of dry p-toluenesulfonic acid were added 
to compound 166 (30 mg, 0.06 mmol) dissolved in CH2Cl2 (5 mL). The mixture was stirred at rt 
until the substrate was consumed (25 h). The reaction mixture was diluted with CH2Cl2 (5 mL), 
and the organic layer was washed with sat. NaHCO3 and brine, dried over anhydrous Na2SO4, 
and concentrated under reduced pressure. Purification by column chromatography over silica gel 
eluting with (hexane/ethyl acetate 1:1) then gave compound 180 as a colorless oil (11 mg, 42%); 
[α]D20 −16.4° (c 0.45, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 5.35 (td, J = 6.0, 2.5 Hz, 1H, H8), 
5.29 (dd, J = 5.9, 3.3 Hz, 1H, H7), 4.60 (dd, J = 12.5, 2.5 Hz, 1H, H9), 4.23 (dd, J = 12.5, 6.0 
Hz, 1H, H9), 4.19 (ddd, J = 12.2, 3.4, 2.1 Hz, 1H, H6), 4.10 − 3.86 (m, 4H), 3.78 (s, 3H, CH3), 
3.23 (s, 3H, CH3), 2.19 (dd, J = 14.2, 2.2 Hz, 1H, H5), 2.13 (s, 3H, CH3), 2.07 (s, 3H, CH3), 2.03 
(s, 3H, CH3), 1.89 (d, J = 14.1 Hz, 1H, H5′), 1.71 (dt, J = 13.2, 2.2 Hz, 1H, H3e), 1.58 (dd, J = 
13.1, 12.1 Hz, 1H, H3a). 13C NMR (151 MHz, CDCl3) δ 170.8, 170.3, 170.2, 168.5, 105.8, 99.3, 
71.9, 70.5, 68.0, 65.5, 64.1, 62.0, 52.7, 51.5, 40.5, 35.8, 21.1, 20.9. HRMS (ESITOF) m/z: [M + 
Na]+ calcd for C19H28NaO12 471.1478; found: 471.1471. 
Methyl (7,8,9-Tri-O-acetyl-2,3,5-tri-deoxy-β-D-arabino-non-2-en-4-oxo-2-
ulopyranosid)onate (182). 
A solution of compound 166 (25 mg, 0.05 mmol), a few drops of wet methanol, and a 
few crystals of p-toluenesulfonic acid in CH2Cl2 (5 mL) were stirred at rt until TLC showed 
complete consumption of the starting material (4 h). The reaction mixture was diluted with 
CH2Cl2 (5 mL), and the organic layer was washed with sat. NaHCO3 and brine, dried over 
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anhydrous Na2SO4, and concentrated under reduced pressure. Purification by column 
chromatography over silica gel eluting with (toluene/ethyl acetate 4:1) gave compound 182 as a 
colorless oil (10 mg, 55%); [α]D20 −26.8° (c 0.2, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 6.24 (d, 
J = 1.1 Hz, 1H, H3), 5.41 (ddd, J = 7.3, 4.9, 2.5 Hz, 1H, H8), 5.38 (dd, J = 7.1, 2.8 Hz, 1H, H7), 
4.71 (ddd, J = 13.5, 3.8, 2.8 Hz, 1H, H6), 4.49 (dd, J = 12.6, 2.5 Hz, 1H, H9), 4.25 (dd, J = 12.6, 
4.9 Hz, 1H, H9), 3.88 (s, 3H, CH3), 2.58 (dd, J = 16.9, 13.6 Hz, 1H, H5), 2.49 (ddd, J = 16.9, 
3.8, 1.1 Hz, 1H, H5′), 2.14 (s, 3H, CH3), 2.08 (s, 3H, CH3), 2.06 (s, 3H, CH3). 
13C NMR (151 
MHz, CDCl3) δ 191.8, 170.7, 169.8, 161.7, 158.3, 109.5, 77.7, 77.4, 77.2, 76.9, 70.1, 69.5, 61.7, 




The nitrosyl sialoside 74 (150 mg, 0.3 mmol) in CH2Cl2 (3 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (68 mg, 0.6 
mmol), 18-crown-6 (74 mg, 0.3 mmol) in CH2Cl2 (2 mL) and HOBt (380 mg, 2.8 mmol, 10 
equiv) in HFIP (2 mL)  to afford 205 after flash column chromatography over silica gel eluting 
with hexane/ ethyl acetate (1:1), as a colorless oil (78 mg, 48%); [α]D
20 + 45.7o (c 0.45, 
CH2Cl2).
1H NMR (600 MHz, CDCl3) δ 7.97 (d, J = 8.4 Hz, 1H, ArH), 7.49 (d, J = 3.5 Hz, 2H, 
ArH), 7.36 (dt, J = 8.0, 3.8 Hz, 1H, ArH), 5.91 (dd, J = 5.0, 2.3 Hz, 1H, H7), 5.60 (ddd, J = 11.0, 
9.4, 5.5 Hz, 1H, H4), 5.39 (ddd, J = 7.3, 5.0, 2.6 Hz, 1H, H8), 4.95 (t, J = 9.7 Hz, 1H, H5), 4.76 
(dd, J = 12.5, 2.6 Hz, 1H, H9), 4.40 (dd, J = 10.1, 2.2 Hz, 1H, H6), 4.20 (dd, J = 12.4, 6.8 Hz, 
1H, H9’), 3.80 (s, 3H, CH3), 3.34 (s, 3H, CH3), 2.60 (dd, J = 13.1, 5.5 Hz, 1H, H3e), 2.32 (s, 3H, 
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CH3), 2.11 (s, 3H, CH3), 2.04 (s, 3H, CH3), 1.67 (dd, J = 13.1, 11.2 Hz, 1H, H3a), 1.12 (s, 3H, 
CH3).
 13C NMR (151 MHz, CDCl3) δ 170.8, 170.6, 170.0, 169.3, 166.9, 143.3, 128.4, 127.9, 
124.8, 120.3, 108.8, 98.7, 82.8, 71.2, 70.0, 69.3, 68.5, 62.3, 52.9, 51.8, 36.8, 21.1, 21.0, 20.9, 
20.1. ESI-HRMS Calcd. for C25H31N3NaO13 :([M+Na]
+) m/z: 604.1755; found: 604.1756. 
Methyl (methyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-5-O-(succinimido-N-yl)-D-glycero-β-D-
galacto-non-2-ulopyranosid)onate (206).  
The nitrosyl sialoside 74 (200 mg, 0.4 mmol) in CH2Cl2 (4 mL) was deaminated using the 
general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (98 mg, 0.8 
mmol), 18-crown-6 (105 mg, 0.4 mmol) in CH2Cl2 (2 mL), and N-hydroxysuccinimide (460 mg, 
4 mmol, 10 equiv) in HFIP (1 mL)  after flash column chromatography over silica gel eluting 
with (hexane/ ethyl acetate 1:1) to afford 206 as a colorless oil in (77 mg, 36%); [α]21 D − 33.6 
(c 0.25, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 5.58 (dd, J = 6.0, 1.8 Hz, 1H, H7), 5.46 (ddd, J = 
10.8, 8.4, 5.2 Hz, 1H, H4), 5.34 (td, J = 6.0, 2.6 Hz, 1H, H8), 4.61 (dd, J = 12.5, 2.7 Hz, 1H, 
H9), 4.27 (dd, J = 9.7, 8.4 Hz, 1H, H5), 4.18 (dd, J = 9.7, 1.9 Hz, 1H, H6), 4.12 (ddd, J = 12.5, 
6.1 Hz, 1H, H9’), 3.79 (s, 3H, CH3), 3.25 (s, 3H, CH3), 2.73 – 2.60 (m, 4H, CH2CH2), 2.55 (dd, J 
= 13.3, 5.3 Hz, 1H, H3e), 2.17 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.04 (s, 3H, CH3), 2.02 (s, 3H, 
CH3), 1.81 (dd, J = 13.3, 10.7 Hz, 1H, H3a). 
13C NMR (151 MHz, CDCl3) δ 171.2, 170.8, 170.4, 
170.3, 169.6, 167.3, 98.4, 79.9, 76.9, 70.5, 69.6, 68.9, 62.1, 52.8, 51.6, 36.4, 21.1, 21.1, 20.9. 
ESI-HRMS Calcd. for C23H31NNaO15 :([M+Na]





The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (90 mg, 0.7 
mmol), 18-crown-6 (195 mg, 0.7 mmol) in CH2Cl2 (2 mL) and N-hydroxyphthalimide (1.2 g, 7.4 
mmol, 20 equiv) to afford 207 after flash column chromatography over silica gel eluting with 
hexane/ ethyl acetate (1:1), as a colorless oil (115 mg, 36%) and 208 as a colorless oil (102 mg, 
27%), and an inseparable mixture of elimination products 160 and 161 as a colorless oil (1:2.5 
ratio, 53 mg, 23%). 
Compound 207; [α]D
20 – 52.0o (c 0.4, CHCl3).
1H NMR (600 MHz, CDCl3) δ 7.82 (dd, J = 
5.5, 3.1 Hz, 2H, ArH), 7.75 (dd, J = 5.5, 3.1 Hz, 2H, ArH), 5.80 (dd, J = 5.3, 2.0 Hz, 1H, H7), 
5.53 (ddd, J = 11.0, 9.0, 5.4 Hz, 1H, H4), 5.39 (ddd, J = 6.7, 5.3, 2.7 Hz, 1H, H8), 4.67 (dd, J = 
12.4, 2.7 Hz, 1H, H9), 4.44 (t, J = 9.4 Hz, 1H, H5), 4.23 (p, J = 9.8, 2.1 Hz, 1H, H6), 4.16 (dd, J 
= 12.4, 6.7 Hz, 1H, H9’), 3.78 (s, 3H, CH3), 3.29 (s, 3H, CH3), 2.66 (dd, J = 13.2, 5.4 Hz, 1H, 
H3e), 2.25 (s, 3H), 2.10 (s, 3H, CH3), 2.04 (s, 3H, CH3), 1.72 (s, 3H, CH3), 1.69 (dd, J = 13.1, 
11.0 Hz, 1H, H3a). 13C NMR (151 MHz, CDCl3) δ 170.8, 170.5, 170.2, 169.4, 167.3, 163.3, 
134.8, 128.9, 123.7, 98.6, 79.5, 71.0, 70.2, 69.4, 68.9, 62.4, 52.8, 51.7, 36.4, 21.1, 21.1, 20.9, 
20.8. ESI-HRMS Calcd. for C27H31NNaO15 :([M+Na]
+) m/z: 632.1591 ; found: 632.1592. 
Methyl (methyl 7,8,9-tri-O-acetyl-3-deoxy-4,5-di-O- (phthalimido-N-yl))-D-glycero-β-D-
galacto-non-2-ulopyranosid)onate (208). 
Compound 208; [α]D
20 – 32.0 o (c 0.25, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 7.79 (dd, J 
= 5.5, 3.1 Hz, 2H, ArH), 7.73 – 7.68 (m, 4H, ArH), 7.67 (dd, J = 5.5, 3.0 Hz, 2H, ArH), 5.79 (dd, 
J = 5.7, 2.1 Hz, 1H, H7), 5.39 (td, J = 6.2, 2.7 Hz, 1H, H8), 5.17 (ddd, J = 10.5, 8.0, 5.5 Hz, 1H, 
H4), 4.86 (dd, J = 9.6, 7.9 Hz, 1H, H5), 4.67 (dd, J = 12.4, 2.7 Hz, 1H, H9), 4.23 (dd, J = 9.6, 2.1 
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Hz, 1H, H6), 4.16 (dd, J = 12.4, 6.5 Hz, 1H, H9’), 3.80 (s, 3H, CH3), 3.23 (s, 3H, CH3), 2.50 (dd, 
J = 13.4, 5.5 Hz, 1H, H3e), 2.32 (s, 3H, CH3), 2.13 (dd, J = 13.4, 10.5 Hz, 1H, H3a), 2.10 (s, 3H, 
CH3), 2.03 (s, 3H, CH3).
 13C NMR (151 MHz, CDCl3) δ 170.9, 170.4, 170.2, 167.4, 163.6, 163.3, 
134.7, 134.3, 129.3, 128.8, 123.8, 123.6, 98.9, 82.5, 78.8, 70.8, 69.2, 68.6, 62.3, 53.0, 51.5, 35.5, 
21.2, 20.9, 14.3. ESI-HRMS Calcd. for C33H32N2NaO16 :([M+Na]




The nitrosyl sialoside 74 (200 mg, 0.4 mmol) in CH2Cl2 (4 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (90 mg, 0.7 
mmol), 18-crown-6 (195 mg, 0.7 mmol) in CH2Cl2 (3 mL) and acetoxyhydroxamic acid (555 
mg, 7.4 mmol, 20 equiv) to afford 209 after flash column chromatography over silica gel eluting 
with hexane/ ethyl acetate (1:1), as a colorless oil (62 mg, 36%) and the single elimination 
product 161 as a colorless oil (46 mg, 28%). 
Compound 209; [α]D
20 – 15.3o (c 0.85, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 5.51 (dd, J 
= 5.6, 2.6 Hz, 1H, H7), 5.34 (td, J = 6.2, 2.6 Hz, 1H. H8), 4.57 (dd, J = 12.5, 2.7 Hz, 1H, H9), 
4.33 (dd, J = 10.0, 2.6 Hz, 1H, H6), 4.22 (dd, J = 12.5, 6.3 Hz, 1H, H9’), 4.17 (dd, J = 10.0, 2.8 
Hz, 1H, H5), 4.04 (dt, J = 4.2, 2.6 Hz, 1H, H4), 3.78 (s, 3H, CH3), 3.23 (s, 3H, CH3), 2.53 (dd, J 
= 15.5, 2.5 Hz, 1H, H3), 2.14 (s, 3H, CH3), 2.10 (dd, J = 15.5, 4.2 Hz, 1H, H3’), 2.07 (s, 3H, 
CH3), 2.03 (s, 3H. CH3), 1.92 (s, 3H, CH3).
 13C NMR (101 MHz, CDCl3) δ 170.7, 170.3, 169.6, 
167.9, 155.2, 97.7, 77.5, 77.2, 76.8, 70.5, 69.1, 68.8, 66.8, 66.1, 62.1, 52.8, 51.8, 34.9, 21.1, 20.8, 
20.8, 17.4. ESI-HRMS Calcd. for C19H27NNaO12 :([M+Na]
+) m/z: 484.1431 ; found: 484.1400.  
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Methyl (methyl 4,7,8,9-tetra-O-acetyl-3,5-dideoxy-β-D-ribo-non-5-en-2-ulopyranosid)onate 
(161). 
Compound 161; [α]D
20 – 57.0o (c 0.5, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 5.54 (ddd, J 
= 7.3, 4.4, 3.0 Hz, 1H, H8), 5.49 (dt, J = 4.6, 1.1 Hz, 1H, H7), 5.28 (dt, J = 5.6, 4.3 Hz, 1H, H4), 
5.10 (dt, J = 4.4, 0.9 Hz, 1H, H5), 4.39 (dd, J = 12.2, 2.8 Hz, 1H, H9), 4.33 (dd, J = 12.2, 7.1 Hz, 
1H, H9’), 3.78 (s, 3H, CH3), 3.39 (s, 3H, CH3), 2.34 (dd, J = 14.2, 4.3 Hz, 1H, H3), 2.20 (dd, J = 
14.2, 5.4 Hz, 1H, H3’), 2.13 (s, 3H, CH3), 2.06 (s, 6H, CH3), 1.99 (s, 3H, CH3). 
13C NMR (101 
MHz, CDCl3) δ 170.8, 170.1, 170.1, 169.3, 167.7, 149.9, 99.3, 98.2, 77.5, 77.2, 76.8, 70.5, 70.4, 
63.1, 62.0, 52.7, 52.2, 34.7, 21.2, 21.0, 20.9.ESI-HRMS Calcd. for C19H26NaO12 :([M+Na]
+) 
m/z: 469.1322 ; found: 469.1322.  
Methyl (methyl 7,8,9-tri-O-acetyl-3,4,5-trideoxy-β-D-arabino-non-4-en-2-
ulopyranosid)onate (211). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and N-(4-methoxybenzyl)acetyl 
hydroxamic caid (975 mg, 5 mmol, 10 equiv) in CH2Cl2 (5 mL) to afford 211 after flash column 
chromatography over silica gel eluting with hexane/ ethyl acetate (3:1), as a colorless oil (41 mg, 
21%) and an inseparable mixture of elimination products 160 and 161 as a colorless oil (40 mg, 
18%). 
Compound 211; [α]D
20 – 10.1o (c 1.3, CHCl3). 
1H NMR (400 MHz, CDCl3) δ 5.82 (ddt, J 
= 10.0, 4.9, 2.3 Hz, 1H, H4), 5.63 (ddt, J = 10.5, 3.0, 1.5 Hz, 1H, H5), 5.45 (td, J = 6.2, 2.3 Hz, 
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1H, H8), 5.37 (dd, J = 6.2, 2.7 Hz, 1H, H7), 4.61 (dd, J = 12.5, 2.3 Hz, 1H. H9), 4.43 (tdq, J = 
4.9, 2.6, 1.5, 0.9 Hz, 1H, H6), 4.22 (dd, J = 12.5, 6.1 Hz, 1H, H9’), 3.80 (s, 3H, CH3), 3.28 (s, 
3H, CH3), 2.40 (ddt, J = 17.8, 4.0, 2.6 Hz, 1H, H3 ), 2.32 (dddd, J = 17.8, 4.8, 3.2, 1.4 Hz, 1H, 
H3’), 2.06 (s, 6H, 2CH3), 2.04 (s, 3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 170.8, 170.1, 170.0, 
169.0, 123.8, 123.8, 97.6, 71.3, 70.3, 69.2, 62.5, 52.6, 51.5, 32.1, 21.0, 20.9, 20.8.ESI-HRMS 
Calcd. for C27H24NaO10 :([M+Na]
+) m/z: 411.1262 ; found: 411.1248. 
Deamination of nitrosyl sialoside 74 with N-(tButyloxycarbonyl)acetyl hydroxamic acid as 
nucleophile.  
Methyl (7,8,9-tri-O-acetyl-3,5-dideoxy-β-D-arabino-non-4-oxo-2-ulopyranosid)onate (212) 
and Methyl (7,8,9-tri-O-acetyl-2,3,5-trideoxy-β-D-arabino-non-2-en-4-oxo-2-ulopyranosid) 
onate (213). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and N-(
tbutyloxycarbonyl)acetyl 
hydroxamic acid (525 mg, 3 mmol, 6 equiv) in CH2Cl2 (5 mL) to afford 211 after flash column 
chromatography over silica gel eluting with hexane/ ethyl acetate (3:1), as a colorless oil (20 mg, 
10%), an inseparable mixture of elimination products 160 and 161 as a colorless oil (91 mg, 
41%) and another inseparable mixture of compounds 212 and 213 (1.27:1 ratio, 35 mg, 17%) as 
a colorless oil. 
Compound 212; 1H NMR (400 MHz, CDCl3) δ 6.24 (d, J = 1.1 Hz, 1H, H3), 5.39 (ddd, J 
= 7.9, 5.3, 2.5 Hz, 1H, H8), 5.38 (dd, J = 7.9, 2.8 Hz, 1H, H7), 4.71 (ddd, J = 13.3, 4.1, 2.7 Hz, 
1H, H6), 4.49 (dd, J = 12.5, 2.3 Hz, 1H, H9), 4.25 (m, 1H, H9), 3.87 (s, 3H, CH3), 2.57 (dd, J = 
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16.9, 13.7 Hz, 1H, H5), 2.48 (dd, J = 16.9, 3.8 Hz, 1H, H5’), 2.14 (s, 3H, CH3), 2.07 (s, 3H, 
CH3), 2.06 (s, 3H, CH3).
 13C NMR (101 MHz, CDCl3) δ 191.8, 170.7, 170.0, 161.7, 158.3, 109.5, 
77.7, 77.4, 77.2, 76.9, 70.1, 69.5, 61.7, 53.4, 37.8, 21.0, 20.8, 20.6.  
Compound 213 was identified in the mixture by the following diagnostic signals; 1H 
NMR (400 MHz, CDCl3) δ 5.35 (ddd, J = 6.0, 5.7, 2.5 Hz, 1H, H8), 5.29 (dd, J = 6.0, 3.1 Hz, 
1H, H7), 4.58 (dd, J=12.5, 2.6 Hz, 1H, H9), 4.25 (m, 1H, H6), 4.21 (dd, J = 12.5, 5.8 Hz, 1H, 
H9’), 3.82 (s, 3H, CH3), 3.24 (s, 3H, CH3), 2.74 (d, J = 14.9 Hz, 1H, H3), 2.61 (d, J = 14.9 Hz, 
1H, H3’), 2.39 (br s, 1H, H5), 2.37 (br s, 1H, H5’), 2.13 (s, 3H, CH3), 2.05 (s, 3H, CH3), 2.04 (s, 
3H, CH3). 
13C NMR (101 MHz, CDCl3) δ 201.6, 170.7, 170.2, 169.8, 167.2, 100.2, 71.3, 70.2, 
69.0, 62.0, 53.0, 51.5, 48.0, 42.1, 21.0, 20.8, 20.8. 
Methyl (methyl 7, 8, 9-tri-O-acetyl-3,5-dideoxy-4-O-(4-nitrophenylmethanimin-N-yl)-β-D-
arabino-non-4-en-2-ulopyranosid)onate (214). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and 4-nitrobenzaldehyde oxime 
(1.66 g, 10 mmol, 20 equiv) in THF (5 mL) to afford 214 after flash column chromatography 
over silica gel eluting with hexane/ ethyl acetate (1:1), as a colorless oil (72 mg, 26%), an 
inseparable mixture of elimination products 160 and 161 as a colorless oil (53 mg, 24%) and 
another inseparable mixture of compounds 212 and 213 (17 mg, 8%) as a colorless oil. 
Compound 214; [α]D
20 – 15.5o (c 0.9, CHCl3). 
1H NMR (600 MHz, CDCl3) δ 8.22 (d, J = 
8.8 Hz, 2H, ArH), 8.02 (s, 1H, NCH), 7.73 (d, J = 8.8 Hz, 2H, ArH), 5.57 (ddd, J = 7.3, 4.5, 2.8 
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Hz, 1H, H8), 5.53 (dt, J = 4.6, 1.2 Hz, 1H, H7), 5.20 (d, J = 4.2 Hz, 1H, H5), 4.87 (dt, J = 6.4, 
5.0 Hz, 1H, H4), 4.42 (dd, J = 12.2, 2.8 Hz, 1H, H9), 4.36 (dd, J = 12.1, 7.4 Hz, 1H, H9’), 3.74 
(s, 3H, CH3), 3.39 (s, 3H, CH3), 2.56 (dd, J = 14.0, 4.8 Hz, 1H, H3), 2.25 (dd, J = 14.0, 5.2 Hz, 
1H, H3’), 2.15 (s, 3H, CH3), 2.07 (s, 3H, CH3), 2.06 (s, 3H, CH3). 
13C NMR (151 MHz, CDCl3) 
δ 170.9, 170.1, 169.4, 167.8, 149.7, 148.6, 147.2, 138.2, 127.8 (2 Carbons), 124.1(2 Carbons), 
99.4, 98.5, 72.3, 70.5, 70.5, 62.0, 52.7, 52.3, 34.7, 21.0, 20.9 (2 Carbons). ESI-HRMS Calcd. for 
C24H28N2NaO13 :([M+Na]
+) m/z: 575.1484 ; found: 575.1486. 
Deamination of nitrosyl sialoside 74 with acetone oxime as nucleophile. The nitrosyl 
sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using the general procedure 
for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 mmol), 18-crown-6 
(291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and acetone oxime (731 mg, 10 mmol, 20 equiv) in 
CH2Cl2 (5 mL) to afford 160 and 161, after flash column chromatography over silica gel eluting 
with hexane/ ethyl acetate (1:1), as a colorless oil (84 mg, 38%). 
Methyl (methyl 7,8,9-tri-O-acetyl-3,4,5-trideoxy-4-N,5-N-phenylaziridinyl-D-glycero-β-D-
talo-non-2-ulopyranosid)onate (215). 
The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and aniline (0.83 mL, 9.2 mmol, 20 
equiv) to afford 215, after flash column chromatography over silica gel eluting with hexane/ 




20 – 45.0o (c 0.5, CH2Cl2).
1H NMR (600 MHz, CDCl3) δ 7.22 (dd, J 
= 8.5, 7.3 Hz, 2H, ArH), 6.98 – 6.94 (m, 3H, ArH), 5.69 (dd, J = 6.0, 3.9 Hz, 1H, H7), 5.52 (td, J 
= 5.9, 2.8 Hz, 1H, H8), 4.59 (dd, J = 12.5, 2.8 Hz, 1H, H9), 4.32 (dd, J = 12.5, 5.9 Hz, 1H, H9’), 
4.16 (t, J = 3.6 Hz, 1H, H6), 3.80 (s, 3H, CH3), 3.22 (s, 3H, CH3), 2.51 (dd, J = 7.1, 3.4 Hz, 1H, 
H5), 2.47 (ddd, J = 7.1, 5.3, 1.7 Hz, 1H, H4), 2.37 (dd, J = 15.3, 1.8 Hz, 1H, H3pe), 2.26 (dd, J = 
15.3, 5.3 Hz, 1H, H3pa), 2.15 (s, 3H, CH3), 2.09 (s, 3H, CH3), 2.08 (s, 3H, CH3).
 13C NMR (151 
MHz, CDCl3) δ 170.8, 170.4, 170.2, 169.4, 153.4, 129.2, 123.1, 120.6, 97.6, 71.4, 70.3, 70.2, 
62.2, 52.7, 52.0, 37.1, 35.3, 31.2, 21.1, 21.0, 20.9. ESI-HRMS Calcd. for C23H29NNaO10 
:([M+Na]+) m/z: 502.1689; found: 502.1682. 
An enhanced yield (130 mg, 56%) of 215 was obtained by stirring the crude mixture at 
room temprarure for 30 minutes. Compound 215 was then isolated using the previousely 
described chromotoghraphic procedure.  
Deamination of nitrosyl sialoside 74 with indole as nucleophile. The nitrosyl sialoside 
74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using the general procedure for 
oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 mmol), 18-crown-6 (291 
mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and indole (1.17 g, 10 mmol, 20 equiv) in CH2Cl2 (5 mL) to 
afford 160 and 161, after flash column chromatography over silica gel eluting with hexane/ ethyl 





The nitrosyl sialoside 74 (267 mg, 0.5 mmol) in CH2Cl2 (5 mL) was deaminated using 
the general procedure for oxidative deamination with sodium 2,2,2-trifluoroethoxide (122 mg, 1 
mmol), 18-crown-6 (291 mg, 1.1 mmol) in CH2Cl2 (2.5 mL) and 3,5-dimethylpyrazole (960 mg, 
10 mmol, 20 equiv) dissolved in HFIP (5 mL) to afford 216, after flash column chromatography 
over silica gel eluting with hexane/ ethyl acetate (3:1), as a colorless oil (31 mg, 9%). 
Compound 216; [α]D
20 – 17.5o (c 1.5, CH2Cl2). 
1H NMR (600 MHz, CDCl3) δ 5.24 (td, J 
= 6.0, 3.4 Hz, 1H, H8), 5.10 (p, J = 6.0 Hz, 1H, CH), 5.03 (t, J = 5.5 Hz, 1H, H7), 4.75 (p, J = 
6.0 Hz, 1H, CH), 4.34 (dd, J = 12.3, 3.4 Hz, 1H, H9), 4.17 (dd, J = 12.3, 6.2 Hz, 1H, H9’), 3.80 
(s, 3H, CH3), 3.71 (ddd, J = 8.7, 6.0, 3.2 Hz, 1H, H4), 3.39 (s, 3H, CH3), 3.11 (dd, J = 8.2, 2.1 
Hz, 1H, H5), 3.02 (dd, J = 5.3, 2.1 Hz, 1H, H6), 2.49 (dd, J = 15.9, 6.1 Hz, 1H, H3a), 2.38 (dd, J 
= 15.9, 3.2 Hz, 1H, H3e), 2.11 (s, 3H, CH3), 2.08 (s, 3H, CH3), 2.05 (s, 3H, CH3).
 13C NMR (151 
MHz, CDCl3) δ 170.6, 170.0, 169.7, 166.7, 101.1, 78.4, 73.5, 73.2, 73.0, 72.8, 72.6, 70.5, 69.8, 
69.6, 69.4, 69.2, 68.9, 68.7, 61.6, 58.4, 53.2, 53.0, 52.7, 36.1, 20.7, 20.7.  
13C{19F,1H}NMR (126 MHz, CDCl3) δ 170.7, 170.0, 169.7, 166.7, 121.7, 121.5, 121.3, 
121.2, 101.2, 78.5, 73.1, 70.5, 69.8, 69.2, 61.6, 58.4, 53.3, 53.1, 52.7, 36.2, 20.8, 20.7. 
19F NMR (471 MHz, CDCl3) δ -75.42 (q, J = 8.0, 7.1 Hz), -75.47 – -75.59 (m), -76.46 (h, 
J = 8.5, 7.3 Hz), -76.80 (qd, J = 9.2, 6.0 Hz). 
ESI-HRMS Calcd. for C23H26F12NaO12 :([M+Na]
+) m/z: 745.1130 ; found: 745.1125. 
Methyl (methyl 4,5,7,8,9-penta-O-acetyl-3-deoxy-D-glycero-β-D-galacto-non-2-
ulopyranosid)onate (75).  
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In a dry round bottom flask, compound 205 (22 mg, 0.04 mmole) was dissolved in 
anhydrous THF (0.2 mL), glacial acetic acid (0.8 mL). Zn-dust (50 mg) was added in one 
portion. The reaction was left under reflux for 2 h until starting material was consumed, and 
formation of the product was monitored by TLC and mass spectrometry. The reaction was then 
quenched with water and filtered through Celite. The filtrate was washed with water and brine. 
The organic layer was dried over anhydrous Na2SO4 and concentrated under reduced pressure. 
The crude mixture was then acetylated using acetic anhydride (1 mL) and pyridine (0.5 mL) at rt 
until the reaction was completed (1 hr). The crude acetylated mixture was purified by column 
chromatography over silica gel eluting with (hexane/ ethyl acetate 1:1) to afford 75 as a white 
foam in (22 mg, 97%). Compound 75; the spectral data is consistent with reported literature.74  
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X-Ray Crystal Structure Determination. 
X-Ray Crystal Structure Determination of 164 (CCDC 1941624) 
Single crystals of 164 C27H30O11 were obtained by slow cooling of a saturated solution in 
diethyl ether. A suitable crystal was selected and mounted on a 'Bruker APEX-II CCD' 
diffractometer. The crystal was kept at 100.1 K during data collection. Using Olex2,152 the 
structure was solved with the ShelXT153 structure solution program using Intrinsic Phasing and 
refined with the ShelXL154 refinement package using Least Squares minimization. 
Refinement model description 
Number of restraints - 0, number of constraints - unknown. 
Details: 
1.Fixed Uiso 
At 1.2 times of: 
All C(H) groups, All C(H,H) groups 
At 1.5 times of: 
All C(H,H,H) groups 
2.a Ternary CH refined with riding coordinates: 
C6(H6), C5(H5), C7(H7), C8(H8), C4(H4) 




2.c Aromatic/amide H refined with riding coordinates: 
 C21(H21), C20(H20), C27(H27), C24(H24), C25(H25), C26(H26) 
2.d Idealised Me refined as rotating group: 
 C16(H16A,H16B,H16C), C15(H15A,H15B,H15C), C13(H13A,H13B,H13C), 
C17(H17A,H17B, 
 H17C), C11(H11A,H11B,H11C) 
Table 10. Crystal data and structure refinement for 164 
Identification code  AW6302_2_0m (164) 
Empirical formula  C27H30O11  
Formula weight  530.51  
Temperature/K  100.1  
Crystal system  orthorhombic  
Space group P212121  
a/Å  6.7275(5)  
b/Å  13.0314(13)  
c/Å  32.146(3)  
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α/°  90  
β/°  90  
γ/°  90  
Volume/Å3  2818.2(4)  
Z  4  
ρcalcg/cm
3  1.250  
μ/mm-1  0.097  
F(000)  1120.0  
Crystal size/mm3  0.415 × 0.391 × 0.242  
Radiation  MoKα (λ = 0.71073)  
2Θ range for data collection/°  2.534 to 50.756  
Index ranges  -8 ≤ h ≤ 7, -15 ≤ k ≤ 15, -38 ≤ l ≤ 35  
Reflections collected  58714  
Independent reflections  5160 [Rint = 0.0566, Rsigma = 0.0419]  
Data/restraints/parameters  5160/0/348  
Goodness-of-fit on F2  1.040  
Final R indexes [I>=2σ (I)]  R1 = 0.0366, wR2 = 0.0758  
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Final R indexes [all data]  R1 = 0.0541, wR2 = 0.0809  
Largest diff. peak/hole / e Å-3  0.18/-0.20  




Table 11. Fractional Atomic Coordinates (×104) and Equivalent Isotropic Displacement 
Parameters (Å2×103) for AW6302_2_0m (164). Ueq is defined as 1/3 of the trace of the 
orthogonalised UIJ tensor. 
Atom x y z U(eq) 
O8 6859(2) 2801.0(12) 7187.3(5) 17.5(4) 
O2 7902(2) 4133.0(13) 6755.1(5) 16.9(4) 
O9 8801(2) 6055.1(12) 6536.2(5) 18.2(4) 
O5 4215(2) 6006.2(12) 7116.1(5) 16.3(4) 
O11 4508(3) 4788.6(13) 5913.6(5) 22.2(4) 
O3 5952(2) 7901.5(13) 6847.8(5) 20.6(4) 
O1 9477(2) 1582.0(13) 6650.7(6) 24.9(5) 
O6 4689(3) 5253.7(15) 7738.7(6) 27.8(5) 
O7 11181(3) 3024.4(15) 6762.1(7) 36.6(5) 
O4 8879(3) 8688.8(14) 6726.6(6) 28.6(5) 
O10 8020(3) 6923.0(17) 5955.3(6) 41.2(6) 
C1 9640(4) 2585(2) 6728.5(8) 17.9(6) 
C19 3478(4) 3982(2) 5749.4(7) 18.3(6) 
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C12 3591(4) 5524.5(18) 7464.4(8) 17.8(6) 
C9 6870(4) 7247.3(19) 7153.6(8) 18.1(6) 
C2 7562(4) 3065.3(19) 6787.1(8) 16.9(6) 
C16 7963(4) 3233(2) 7527.6(8) 18.9(6) 
C6 6353(3) 4694.4(18) 6549.9(7) 15.7(6) 
C14 9246(4) 6642(2) 6201.4(8) 23.0(6) 
C5 6324(4) 4375.5(19) 6097.5(8) 17.8(6) 
C3 6018(3) 2681.9(19) 6482.9(8) 16.2(6) 
C21 743(4) 3248(2) 5395.4(8) 26.1(7) 
C7 6735(4) 5818.9(19) 6616.3(8) 16.2(6) 
C8 6341(3) 6151.3(19) 7063.2(7) 15.6(6) 
C4 6237(4) 3190.2(18) 6053.9(7) 16.5(6) 
C10 7137(4) 8601(2) 6655.4(8) 23.3(6) 
C22 1624(4) 2272(2) 5427.0(8) 24.9(7) 
C20 1642(4) 4113(2) 5549.7(7) 23.5(7) 
C18 4387(4) 3054.3(19) 5793.4(7) 16.9(6) 
C23 3519(4) 2171(2) 5625.3(7) 20.7(6) 
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C15 11410(4) 6863(2) 6185.4(9) 30.6(7) 
C13 1398(4) 5372(2) 7449.4(8) 23.1(6) 
C27 4420(5) 1186(2) 5636.6(8) 28.5(7) 
C17 11321(4) 1023(2) 6605.2(9) 27.1(7) 
C24 703(5) 1386(2) 5261.0(9) 36.5(8) 
C11 5982(5) 9206(2) 6347.1(9) 35.6(8) 
C25 1595(6) 455(3) 5279.5(9) 47.2(9) 
C26 3490(5) 354(2) 5465.8(9) 39.6(8) 
  
 
Table 12. Anisotropic Displacement Parameters (Å2×103) for AW6302_2_0m (164). The 
Anisotropic displacement factor exponent takes the form: -2π2[h2a*2U11+2hka*b*U12+…]. 
Atom U11 U22 U33 U23 U13 U12 
O8 16.6(8) 21.4(10) 14.4(9) 0.2(8) 0.2(8) -1.8(8) 
O2 15.3(8) 14.0(10) 21.4(9) 1.9(8) -3.9(7) -0.6(7) 
O9 14.4(8) 18.6(10) 21.7(9) 3.4(8) 4.2(8) -0.7(8) 
O5 11.0(8) 20.1(10) 17.9(9) 1.2(8) 2.0(7) 0.2(7) 
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O11 24.5(9) 18.9(10) 23.2(10) -2.2(8) -8.8(8) 5.6(8) 
O3 22.5(9) 14.8(10) 24.6(10) 2.2(8) -2.2(8) -1.0(8) 
O1 15.1(9) 16.5(11) 43.1(12) 1.3(9) 4.1(8) 3.6(8) 
O6 20.5(9) 36.0(12) 26.8(10) 11.3(9) 0.7(9) 3.6(9) 
O7 15.3(10) 27.2(12) 67.4(15) -13.6(10) 3.7(10) -1.1(9) 
O4 29.7(11) 23.5(11) 32.5(11) 3.1(9) 2.8(9) -4.1(9) 
O10 40.1(12) 53.5(15) 30.1(12) 19.4(11) -3.6(11) -8.6(11) 
C1 15.9(13) 18.8(16) 19.1(14) 2.4(12) 1.1(11) -0.2(12) 
C19 18.4(13) 24.6(16) 12.0(13) -3.3(12) 0.8(11) 1.7(12) 
C12 18.4(13) 13.6(14) 21.3(15) 1.3(12) 2.9(12) -0.1(11) 
C9 16.7(12) 21.2(15) 16.4(13) 1.9(12) -2.0(11) 2.3(11) 
C2 18.9(13) 15.9(15) 15.8(14) 3.0(12) 2.8(11) -2.0(11) 
C16 18.8(13) 19.5(15) 18.3(14) 2.8(12) -0.6(12) 0.0(11) 
C6 11.7(12) 16.7(14) 18.7(13) 3.4(11) 0.4(11) 2.5(11) 
C14 30.9(16) 17.1(15) 21.0(15) -0.1(12) 7.6(14) -1.4(13) 
C5 16.2(12) 18.2(14) 19.2(14) 1.5(11) 0.7(11) 1.3(11) 
C3 11.4(12) 16.2(14) 21.1(14) -0.6(11) -0.4(10) 0.2(11) 
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C21 19.8(14) 45(2) 13.6(14) 2.1(13) -2.5(11) -3.6(14) 
C7 11.6(12) 18.9(15) 18.1(13) 1.0(11) 0.5(11) -0.9(11) 
C8 8.0(11) 20.1(15) 18.9(13) 1.8(11) -1.2(10) -1.2(11) 
C4 15.3(12) 17.2(14) 16.9(13) -1.6(11) 3.1(11) 2.0(11) 
C10 30.8(17) 16.8(15) 22.3(15) -4.1(13) 0.9(13) 1.8(13) 
C22 27.2(15) 34.8(19) 12.9(13) 1.3(12) -1.3(12) -10.2(14) 
C20 22.0(14) 34.0(18) 14.5(13) -0.4(13) 0.2(11) 10.0(13) 
C18 17.8(13) 20.1(15) 12.9(12) -0.7(11) 2.2(11) 1.1(12) 
C23 28.4(14) 22.9(16) 10.8(13) 1.5(11) 0.2(12) -3.4(13) 
C15 29.4(15) 25.5(17) 36.9(17) 1.5(13) 11.3(14) -6.2(13) 
C13 20.3(13) 23.4(16) 25.6(15) 0.0(12) 3.3(12) -3.9(12) 
C27 44.7(17) 24.6(18) 16.1(14) 1.8(12) -5.7(13) -5.7(15) 
C17 18.4(13) 18.1(15) 44.8(17) -0.1(13) 8.1(13) 3.8(12) 
C24 47(2) 43(2) 19.3(15) 5.5(15) -7.9(14) -22.2(18) 
C11 47.6(19) 26.1(17) 33.2(17) 7.2(14) -2.7(15) 6.7(15) 
C25 77(3) 36(2) 28.6(17) 4.8(15) -20.2(18) -24(2) 
C26 74(2) 19.9(17) 24.9(16) 1.0(13) -11.6(17) -5.2(17) 
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Table 13. Bond Lengths for AW6302_2_0m (164) 
Atom Atom Length/Å   Atom Atom Length/Å 
O8 C2 1.413(3)   C12 C13 1.490(3) 
O8 C16 1.437(3)   C9 C8 1.500(4) 
O2 C2 1.414(3)   C2 C3 1.512(3) 
O2 C6 1.434(3)   C6 C5 1.513(3) 
O9 C14 1.354(3)   C6 C7 1.503(4) 
O9 C7 1.446(3)   C14 C15 1.485(4) 
O5 C12 1.350(3)   C5 C4 1.552(4) 
O5 C8 1.453(3)   C3 C4 1.537(3) 
O11 C19 1.365(3)   C21 C22 1.406(4) 
O11 C5 1.460(3)   C21 C20 1.372(4) 
O3 C9 1.440(3)   C7 C8 1.524(3) 
O3 C10 1.360(3)   C4 C18 1.510(4) 
O1 C1 1.335(3)   C10 C11 1.486(4) 
O1 C17 1.446(3)   C22 C23 1.431(4) 
O6 C12 1.203(3)   C22 C24 1.415(4) 
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O7 C1 1.189(3)   C18 C23 1.400(4) 
O4 C10 1.200(3)   C23 C27 1.420(4) 
O10 C14 1.200(3)   C27 C26 1.367(4) 
C1 C2 1.544(3)   C24 C25 1.355(5) 
C19 C20 1.403(4)   C25 C26 1.415(5) 
C19 C18 1.363(4)         
 
Table 14. Bond Angles for AW6302_2_0m (164). 
Atom Atom Atom Angle/˚   Atom Atom Atom Angle/˚ 
C2 O8 C16 115.11(18)   O11 C5 C4 107.4(2) 
C2 O2 C6 114.70(18)   C6 C5 C4 111.1(2) 
C14 O9 C7 118.32(19)   C2 C3 C4 111.8(2) 
C12 O5 C8 117.62(18)   C20 C21 C22 122.1(2) 
C19 O11 C5 107.32(18)   O9 C7 C6 110.27(19) 
C10 O3 C9 117.13(19)   O9 C7 C8 105.95(18) 
C1 O1 C17 116.2(2)   C6 C7 C8 112.4(2) 
O1 C1 C2 110.2(2)   O5 C8 C9 109.55(19) 
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O7 C1 O1 124.1(2)   O5 C8 C7 104.18(18) 
O7 C1 C2 125.7(2)   C9 C8 C7 114.3(2) 
O11 C19 C20 122.0(2)   C3 C4 C5 110.6(2) 
C18 C19 O11 114.5(2)   C18 C4 C5 101.41(19) 
C18 C19 C20 123.4(2)   C18 C4 C3 111.6(2) 
O5 C12 C13 110.1(2)   O3 C10 C11 110.7(2) 
O6 C12 O5 123.6(2)   O4 C10 O3 123.3(2) 
O6 C12 C13 126.3(2)   O4 C10 C11 126.0(3) 
O3 C9 C8 109.25(19)   C21 C22 C23 119.4(2) 
O8 C2 O2 111.1(2)   C21 C22 C24 121.7(3) 
O8 C2 C1 108.4(2)   C24 C22 C23 118.9(3) 
O8 C2 C3 106.16(19)   C21 C20 C19 117.0(3) 
O2 C2 C1 104.11(19)   C19 C18 C4 108.9(2) 
O2 C2 C3 112.9(2)   C19 C18 C23 120.2(2) 
C3 C2 C1 114.2(2)   C23 C18 C4 130.9(2) 
O2 C6 C5 108.16(19)   C18 C23 C22 117.9(2) 
O2 C6 C7 107.92(19)   C18 C23 C27 123.7(2) 
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C7 C6 C5 114.0(2)   C27 C23 C22 118.4(2) 
O9 C14 C15 110.7(2)   C26 C27 C23 120.7(3) 
O10 C14 O9 123.0(2)   C25 C24 C22 121.3(3) 
O10 C14 C15 126.3(2)   C24 C25 C26 120.1(3) 
O11 C5 C6 107.38(19)   C27 C26 C25 120.6(3) 
 
Table 15. Hydrogen Atom Coordinates (Å×104) and Isotropic Displacement Parameters 
(Å2×103) for AW6302_2_0m (164). 
Atom x y z U(eq) 
H9A 6400.27 7437.09 7435.1 22 
H9B 8331.11 7334.36 7145.07 22 
H16A 7699.85 2837.03 7780.94 28 
H16B 7555.86 3946.97 7570.06 28 
H16C 9386.77 3208.06 7463.8 28 
H6 5049.55 4511.05 6679.52 19 
H5 7517.66 4652.45 5949.91 21 
H3A 4675.36 2827.24 6594.31 19 
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H3B 6150.84 1929.01 6452.41 19 
H21 -513.53 3309.56 5263.08 31 
H7 5876.4 6227 6423.77 19 
H8 7075.1 5689.35 7258.35 19 
H4 7435.7 2924.17 5904.8 20 
H20 1047.22 4771.04 5522.41 28 
H15A 12152.8 6216.07 6184.41 46 
H15B 11790.65 7268.82 6429.28 46 
H15C 11713.55 7249.67 5931.78 46 
H13A 1047.12 4986.31 7198.28 35 
H13B 734.26 6041.81 7444.18 35 
H13C 968.79 4989.15 7695.83 35 
H27 5684.15 1104.3 5764.26 34 
H17A 12153.84 1136.18 6851.15 41 
H17B 12023.23 1266.09 6356.87 41 
H17C 11036.62 289.17 6576.8 41 
H24 -567.08 1444.78 5133.93 44 
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H11A 6213.59 9939.96 6393.47 53 
H11B 4562.92 9056.38 6379.21 53 
H11C 6408.22 9021.86 6065.36 53 
H25 947.42 -130.73 5167.3 57 
H26 4121.79 -297.72 5472.3 47 
 
Table 16. Solvent masks information for AW6302_2_0m (164). 
Number X Y Z Volume Electron count Content 
1 -0.479 0.250 0.000 175.5 37.2 ? 
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EXPLORING THE SCOPE AND LIMITATIONS OF THE OXIDATIVE 
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 Sialic acids are molecules of importance in the fields of carbohydrate chemistry 
and glycoscience, and their diversity make them even more attractive to scientific research. 
Modifications of sialic acid derivatives may lead to several biological and chemical features that 
can be utilized for medicinal purposes. The modern drug therapy is dependent on the chemical 
discoveries of potent and effective molecules. N-Acetyl neuraminic acid is the parent and most 
common molecule in sialic acid family that received considerable attention in glycochemical 
research. This dissertation explores the scope as well as the limitations of the Zbiral oxidative 
deamination of N-acetyl neuraminic acid (NeuAc) by using various nucleophiles and protecting 
groups leading to the discovery of new general reaction pathway that may be useful for organic 
synthesis. 
Chapter one discusses an overview and definition of carbohydrates and their importance 
in biology and chemistry. Common monosaccharides as well as construction of polysaccharides 
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by the glycosidic linkages are defined. These are followed by brief discussion about sialic acid 
discovery as well as explanation of their diverse presence in nature. In chapter one also general 
discussion about deamination reaction is introduced. This is supported by literature review of 
sialic acid modification approaches. Finally, previously reported examples of oxidative 
deamination utilization in carbohydrate syntheses are also presented.  
Chapter two proves that use of phenols and thiophenols are effective as nucleophiles for 
oxidative deamination of NeuAc with the discovery of novel intermediate vinyl diazonium ion. 
Firstly, chapter one introduces brief literature examples of a ring atom participation as well as 
ring contractions followed by earlier reported synthetic pathways of alkenediazonium ions. Then, 
novel and unusual structures of neuraminic acid derivatives are described to be isolated and 
characterized by the use of phenols nucleophiles in modified conditions of oxidative 
deamination. The weakly acidic nature of phenols plays an important role in the formation of the 
vinyl diazonium ion intermediate, which was a result of β-elimination of 4-acetoxy group after 
diazonium ion and diazoalkane interconversion. This is influenced by the pKa values of the 
nucleophiles that lead to the formation of the variety of products. Finally, the plausible 
mechanisms of products formation are explained according to the acidity of the reaction media.  
Chapter three further supports the finding of the formation of vinyl diazonium ion as an 
intermediate, which afforded new products of sialic acid derivatives. Furthermore, chapter three 
describes the expansion of the range of nucleophiles for oxidative deamination of N-acetyl 
neuraminic acid showing that modifications at the 5-position of NeuAc by building N-O bond 
are accomplishable. Hydroxylamines, hydroxamic acids, oximes, amines are the nucleophile 
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used to isolate structurally novel cyclic and substitution products with potential medicinal 
applications. 
Chapter four illustrates the conclusions and the main contributions in this dissertation 
giving an overall reaction mechanism of the products formation in this oxidative deamination.  
Chapter five describes the substrates syntheses and experimental procedures as well as 
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